Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Vaccines

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 473 articles:
HTML format
Text format



Single Articles


    January 2017
  1. HUBER B, Schellenbacher C, Shafti-Keramat S, Jindra C, et al
    Chimeric L2-Based Virus-Like Particle (VLP) Vaccines Targeting Cutaneous Human Papillomaviruses (HPV).
    PLoS One. 2017;12:e0169533.
    PubMed     Text format     Abstract available


  2. REN ST, Zhang XM, Sun PF, Sun LJ, et al
    Intranasal Immunization Using Mannatide as a Novel Adjuvant for an Inactivated Influenza Vaccine and Its Adjuvant Effect Compared with MF59.
    PLoS One. 2017;12:e0169501.
    PubMed     Text format     Abstract available


  3. MCCOLLUM ED, Nambiar B, Deula R, Zadutsa B, et al
    Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Clinical and Hypoxemic Childhood Pneumonia over Three Years in Central Malawi: An Observational Study.
    PLoS One. 2017;12:e0168209.
    PubMed     Text format     Abstract available


  4. MARTORELLI L, Garbaccio S, Vilte DA, Albanese AA, et al
    Immune Response in Calves Vaccinated with Type Three Secretion System Antigens and Shiga Toxin 2B Subunit of Escherichia coli O157:H7.
    PLoS One. 2017;12:e0169422.
    PubMed     Text format     Abstract available


  5. SLIKE BM, Creegan M, Marovich M, Ngauy V, et al
    Humoral Immunity to Primary Smallpox Vaccination: Impact of Childhood versus Adult Immunization on Vaccinia Vector Vaccine Development in Military Populations.
    PLoS One. 2017;12:e0169247.
    PubMed     Text format     Abstract available


  6. SMETANA J, Chlibek R, Hanovcova I, Sosovickova R, et al
    Decreasing Seroprevalence of Measles Antibodies after Vaccination - Possible Gap in Measles Protection in Adults in the Czech Republic.
    PLoS One. 2017;12:e0170257.
    PubMed     Text format     Abstract available


  7. HE Y, Sultana I, Takeda K, Reed JL, et al
    Cutaneous Deficiency of Filaggrin and STAT3 Exacerbates Vaccinia Disease In Vivo.
    PLoS One. 2017;12:e0170070.
    PubMed     Text format     Abstract available


  8. LU D, Qiao Y, Brown NE, Wang J, et al
    Racial and Ethnic Disparities in Influenza Vaccination among Adults with Chronic Medical Conditions Vary by Age in the United States.
    PLoS One. 2017;12:e0169679.
    PubMed     Text format     Abstract available


  9. BAWANKULE R, Singh A, Kumar K, Shetye S, et al
    Does Measles Vaccination Reduce the Risk of Acute Respiratory Infection (ARI) and Diarrhea in Children: A Multi-Country Study?
    PLoS One. 2017;12:e0169713.
    PubMed     Text format     Abstract available


  10. LEE HJ, Lee JY, Park MH, Kim JY, et al
    Monoclonal Antibody against G Glycoprotein Increases Respiratory Syncytial Virus Clearance In Vivo and Prevents Vaccine-Enhanced Diseases.
    PLoS One. 2017;12:e0169139.
    PubMed     Text format     Abstract available


  11. SERRANO M, Elguezabal N, Sevilla IA, Geijo MV, et al
    Tuberculosis Detection in Paratuberculosis Vaccinated Calves: New Alternatives against Interference.
    PLoS One. 2017;12:e0169735.
    PubMed     Text format     Abstract available


  12. DARVISHIAN M, Dijkstra F, van Doorn E, Bijlsma MJ, et al
    Influenza Vaccine Effectiveness in the Netherlands from 2003/2004 through 2013/2014: The Importance of Circulating Influenza Virus Types and Subtypes.
    PLoS One. 2017;12:e0169528.
    PubMed     Text format     Abstract available


  13. FALKENHORST G, Remschmidt C, Harder T, Hummers-Pradier E, et al
    Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) against Pneumococcal Disease in the Elderly: Systematic Review and Meta-Analysis.
    PLoS One. 2017;12:e0169368.
    PubMed     Text format     Abstract available


  14. WANG J, Su C, Liu R, Liu B, et al
    A Pre-Clinical Safety Evaluation of SBP (HBsAg-Binding Protein) Adjuvant for Hepatitis B Vaccine.
    PLoS One. 2017;12:e0170313.
    PubMed     Text format     Abstract available


  15. TOSTES RO, Rodrigues TC, da Silva JB, Schanoski AS, et al
    Protection Elicited by Nasal Immunization with Recombinant Pneumococcal Surface Protein A (rPspA) Adjuvanted with Whole-Cell Pertussis Vaccine (wP) against Co-Colonization of Mice with Streptococcus pneumoniae.
    PLoS One. 2017;12:e0170157.
    PubMed     Text format     Abstract available


  16. PRAPHASIRI P, Ditsungneon D, Greenbaum A, Dawood FS, et al
    Do Thai Physicians Recommend Seasonal Influenza Vaccines to Pregnant Women? A Cross-Sectional Survey of Physicians' Perspectives and Practices in Thailand.
    PLoS One. 2017;12:e0169221.
    PubMed     Text format     Abstract available


  17. HOWARD LM, Hoek KL, Goll JB, Samir P, et al
    Cell-Based Systems Biology Analysis of Human AS03-Adjuvanted H5N1 Avian Influenza Vaccine Responses: A Phase I Randomized Controlled Trial.
    PLoS One. 2017;12:e0167488.
    PubMed     Text format     Abstract available


  18. LI K, Wei G, Cao Y, Li D, et al
    The Identification and Distribution of Cattle XCR1 and XCL1 among Peripheral Blood Cells: New Insights into the Design of Dendritic Cells Targeted Veterinary Vaccine.
    PLoS One. 2017;12:e0170575.
    PubMed     Text format     Abstract available


  19. DE SERRES G, Skowronski DM, Ward BJ, Gardam M, et al
    Influenza Vaccination of Healthcare Workers: Critical Analysis of the Evidence for Patient Benefit Underpinning Policies of Enforcement.
    PLoS One. 2017;12:e0163586.
    PubMed     Text format     Abstract available


  20. HAYWARD AC
    Influenza Vaccination of Healthcare Workers Is an Important Approach for Reducing Transmission of Influenza from Staff to Vulnerable Patients.
    PLoS One. 2017;12:e0169023.
    PubMed     Text format    


  21. SECORE S, Wang S, Doughtry J, Xie J, et al
    Development of a Novel Vaccine Containing Binary Toxin for the Prevention of Clostridium difficile Disease with Enhanced Efficacy against NAP1 Strains.
    PLoS One. 2017;12:e0170640.
    PubMed     Text format     Abstract available


  22. SCHMID P, Rauber D, Betsch C, Lidolt G, et al
    Barriers of Influenza Vaccination Intention and Behavior - A Systematic Review of Influenza Vaccine Hesitancy, 2005 - 2016.
    PLoS One. 2017;12:e0170550.
    PubMed     Text format     Abstract available


  23. HJALMARSDOTTIR MA, Quirk SJ, Haraldsson G, Erlendsdottir H, et al
    Comparison of Serotype Prevalence of Pneumococci Isolated from Middle Ear, Lower Respiratory Tract and Invasive Disease Prior to Vaccination in Iceland.
    PLoS One. 2017;12:e0169210.
    PubMed     Text format     Abstract available


  24. GORMLEY E, Ni Bhuachalla D, O'Keeffe J, Murphy D, et al
    Oral Vaccination of Free-Living Badgers (Meles meles) with Bacille Calmette Guerin (BCG) Vaccine Confers Protection against Tuberculosis.
    PLoS One. 2017;12:e0168851.
    PubMed     Text format     Abstract available


  25. MOISI JC, Makawa MS, Tall H, Agbenoko K, et al
    Burden of Pneumococcal Disease in Northern Togo before the Introduction of Pneumococcal Conjugate Vaccine.
    PLoS One. 2017;12:e0170412.
    PubMed     Text format     Abstract available


  26. MA L, Wang X, Bi X, Yang J, et al
    Characteristics Peripheral Blood IgG and IgM Heavy Chain Complementarity Determining Region 3 Repertoire before and after Immunization with Recombinant HBV Vaccine.
    PLoS One. 2017;12:e0170479.
    PubMed     Text format     Abstract available


  27. BURGHOUTS J, Del Nogal B, Uriepero A, Hermans PW, et al
    Childhood Vaccine Acceptance and Refusal among Warao Amerindian Caregivers in Venezuela; A Qualitative Approach.
    PLoS One. 2017;12:e0170227.
    PubMed     Text format     Abstract available


  28. FU Y, Li P, Cao Y, Wang N, et al
    Development of a Blocking ELISA Using a Monoclonal Antibody to a Dominant Epitope in Non-Structural Protein 3A of Foot-and-Mouth Disease Virus, as a Matching Test for a Negative-Marker Vaccine.
    PLoS One. 2017;12:e0170560.
    PubMed     Text format     Abstract available


  29. AIYEGBO MS, Shmelkov E, Dominguez L, Goger M, et al
    Peptide Targeted by Human Antibodies Associated with HIV Vaccine-Associated Protection Assumes a Dynamic alpha-Helical Structure.
    PLoS One. 2017;12:e0170530.
    PubMed     Text format     Abstract available


  30. ELAISH M, Ngunjiri JM, Ali A, Xia M, et al
    Supplementation of inactivated influenza vaccine with norovirus P particle-M2e chimeric vaccine enhances protection against heterologous virus challenge in chickens.
    PLoS One. 2017;12:e0171174.
    PubMed     Text format     Abstract available


  31. CILVETI R, Olmo M, Perez-Jove J, Picazo JJ, et al
    Epidemiology of Otitis Media with Spontaneous Perforation of the Tympanic Membrane in Young Children and Association with Bacterial Nasopharyngeal Carriage, Recurrences and Pneumococcal Vaccination in Catalonia, Spain - The Prospective HERMES Study.
    PLoS One. 2017;12:e0170316.
    PubMed     Text format     Abstract available


  32. ZHANG X, Mu Y, Mu P, Ao J, et al
    Transcriptome Analysis Reveals Comprehensive Insights into the Early Immune Response of Large Yellow Croaker (Larimichthys crocea) Induced by Trivalent Bacterial Vaccine.
    PLoS One. 2017;12:e0170958.
    PubMed     Text format     Abstract available


  33. ZHANG A, Lai H, Xu J, Huang W, et al
    Evaluation of the Protective Efficacy of Poly I:C as an Adjuvant for H9N2 Subtype Avian Influenza Inactivated Vaccine and Its Mechanism of Action in Ducks.
    PLoS One. 2017;12:e0170681.
    PubMed     Text format     Abstract available


  34. MARANA MH, Jorgensen LV, Skov J, Chettri JK, et al
    Subunit vaccine candidates against Aeromonas salmonicida in rainbow trout Oncorhynchus mykiss.
    PLoS One. 2017;12:e0171944.
    PubMed     Text format     Abstract available


  35. QU F, Weschler LB, Sun Y, Sundell J, et al
    High pneumonia lifetime-ever incidence in Beijing children compared with locations in other countries, and implications for national PCV and Hib vaccination.
    PLoS One. 2017;12:e0171438.
    PubMed     Text format     Abstract available


  36. OVSYANNIKOVA IG, Schaid DJ, Larrabee BR, Haralambieva IH, et al
    A large population-based association study between HLA and KIR genotypes and measles vaccine antibody responses.
    PLoS One. 2017;12:e0171261.
    PubMed     Text format     Abstract available


  37. PICAZO J, Ruiz-Contreras J, Casado-Flores J, Negreira S, et al
    Effect of the different 13-valent pneumococcal conjugate vaccination uptakes on the invasive pneumococcal disease in children: Analysis of a hospital-based and population-based surveillance study in Madrid, Spain, 2007-2015.
    PLoS One. 2017;12:e0172222.
    PubMed     Text format     Abstract available


  38. GUTHRIE JL, Fisman D, Gardy JL
    Self-rated health and reasons for non-vaccination against seasonal influenza in Canadian adults with asthma.
    PLoS One. 2017;12:e0172117.
    PubMed     Text format     Abstract available


  39. ROJO JU, Melkus MW, Kottapalli KR, Okiya OE, et al
    Sm-p80-based schistosomiasis vaccine mediated epistatic interactions identified potential immune signatures for vaccine efficacy in mice and baboons.
    PLoS One. 2017;12:e0171677.
    PubMed     Text format     Abstract available


  40. MENG FY, Sun Y, Shen YG, Pan HF, et al
    Safety of measles-containing vaccines in post-marketing surveillance in Anhui, China.
    PLoS One. 2017;12:e0172108.
    PubMed     Text format     Abstract available


  41. DE GROOT AS, Tounkara K, Rochas M, Beseme S, et al
    Knowledge, attitudes, practices and willingness to vaccinate in preparation for the introduction of HPV vaccines in Bamako, Mali.
    PLoS One. 2017;12:e0171631.
    PubMed     Text format     Abstract available


  42. DOMINGUEZ A, Soldevila N, Toledo D, Torner N, et al
    Effectiveness of 23-valent pneumococcal polysaccharide vaccination in preventing community-acquired pneumonia hospitalization and severe outcomes in the elderly in Spain.
    PLoS One. 2017;12:e0171943.
    PubMed     Text format     Abstract available


  43. HRADILOVA N, Sadilkova L, Palata O, Mysikova D, et al
    Generation of dendritic cell-based vaccine using high hydrostatic pressure for non-small cell lung cancer immunotherapy.
    PLoS One. 2017;12:e0171539.
    PubMed     Text format     Abstract available


  44. SALIH DA, Pelle R, Mwacharo JM, Njahira MN, et al
    Genes encoding two Theileria parva antigens recognized by CD8+ T-cells exhibit sequence diversity in South Sudanese cattle populations but the majority of alleles are similar to the Muguga component of the live vaccine cocktail.
    PLoS One. 2017;12:e0171426.
    PubMed     Text format     Abstract available


  45. TEGUETE I, Dolo A, Sangare K, Sissoko A, et al
    Prevalence of HPV 16 and 18 and attitudes toward HPV vaccination trials in patients with cervical cancer in Mali.
    PLoS One. 2017;12:e0172661.
    PubMed     Text format     Abstract available


  46. DALGIC OO, Ozaltin OY, Ciccotelli WA, Erenay FS, et al
    Deriving effective vaccine allocation strategies for pandemic influenza: Comparison of an agent-based simulation and a compartmental model.
    PLoS One. 2017;12:e0172261.
    PubMed     Text format     Abstract available


  47. MARIN D, Marin N, Del Corral H, Lopez L, et al
    PPD-induced monocyte mitochondrial damage is associated with a protective effect to develop tuberculosis in BCG vaccinated individuals: A cohort study.
    PLoS One. 2017;12:e0171930.
    PubMed     Text format     Abstract available


  48. HOLUBAR M, Stavroulakis MC, Maldonado Y, Ioannidis JP, et al
    Impact of vaccine herd-protection effects in cost-effectiveness analyses of childhood vaccinations. A quantitative comparative analysis.
    PLoS One. 2017;12:e0172414.
    PubMed     Text format     Abstract available


  49. PALMU AA, Rinta-Kokko H, Nohynek H, Nuorti JP, et al
    Impact of ten-valent pneumococcal conjugate vaccine on pneumonia in Finnish children in a nation-wide population-based study.
    PLoS One. 2017;12:e0172690.
    PubMed     Text format     Abstract available


  50. GULLBERG M, Lohse L, Botner A, McInerney GM, et al
    Correction: A Prime-Boost Vaccination Strategy in Cattle to Prevent Foot-and-Mouth Disease Using a "Single-Cycle" Alphavirus Vector and Empty Capsid Particles.
    PLoS One. 2017;12:e0173327.
    PubMed     Text format     Abstract available


  51. MORAES-SOUZA RQ, Reinaque AP, Soares TS, Silva AL, et al
    Safety evaluation of a vaccine: Effect in maternal reproductive outcome and fetal anomaly frequency in rats using a leishmanial vaccine as a model.
    PLoS One. 2017;12:e0172525.
    PubMed     Text format     Abstract available


  52. MARTI M, de Cola M, MacDonald NE, Dumolard L, et al
    Assessments of global drivers of vaccine hesitancy in 2014-Looking beyond safety concerns.
    PLoS One. 2017;12:e0172310.
    PubMed     Text format     Abstract available


  53. GALEA JT, Monsour E, Nurena CR, Blas MM, et al
    HPV vaccine knowledge and acceptability among Peruvian men who have sex with men and transgender women: A pilot, qualitative study.
    PLoS One. 2017;12:e0172964.
    PubMed     Text format     Abstract available


  54. WEN G, Li L, Yu Q, Wang H, et al
    Evaluation of a thermostable Newcastle disease virus strain TS09-C as an in-ovo vaccine for chickens.
    PLoS One. 2017;12:e0172812.
    PubMed     Text format     Abstract available


  55. CHAPMAN R, Jongwe TI, Douglass N, Chege G, et al
    Heterologous prime-boost vaccination with DNA and MVA vaccines, expressing HIV-1 subtype C mosaic Gag virus-like particles, is highly immunogenic in mice.
    PLoS One. 2017;12:e0173352.
    PubMed     Text format     Abstract available


  56. ISLAM MA, Grosse-Brinkhaus C, Proll MJ, Uddin MJ, et al
    PBMC transcriptome profiles identifies potential candidate genes and functional networks controlling the innate and the adaptive immune response to PRRSV vaccine in Pietrain pig.
    PLoS One. 2017;12:e0171828.
    PubMed     Text format     Abstract available


  57. DAYER JA, Siegrist CA, Huttner A
    Volunteer feedback and perceptions after participation in a phase I, first-in-human Ebola vaccine trial: An anonymous survey.
    PLoS One. 2017;12:e0173148.
    PubMed     Text format     Abstract available


  58. TEFERI WM, Desaulniers MA, Noyce RS, Shenouda M, et al
    The vaccinia virus K7 protein promotes histone methylation associated with heterochromatin formation.
    PLoS One. 2017;12:e0173056.
    PubMed     Text format     Abstract available


  59. HEQUET D, Rouzier R
    Determinants of geographic inequalities in HPV vaccination in the most populated region of France.
    PLoS One. 2017;12:e0172906.
    PubMed     Text format     Abstract available


  60. KIM JI, Lee I, Park S, Bae JY, et al
    Phylogenetic relationships of the HA and NA genes between vaccine and seasonal influenza A(H3N2) strains in Korea.
    PLoS One. 2017;12:e0172059.
    PubMed     Text format     Abstract available


  61. ESQUERRE M, Bouillette-Marussig M, Goubier A, Momot M, et al
    GTL001, a bivalent therapeutic vaccine against human papillomavirus 16 and 18, induces antigen-specific CD8+ T cell responses leading to tumor regression.
    PLoS One. 2017;12:e0174038.
    PubMed     Text format     Abstract available


  62. LAURENS MB, Kouriba B, Bergmann-Leitner E, Angov E, et al
    Strain-specific Plasmodium falciparum growth inhibition among Malian children immunized with a blood-stage malaria vaccine.
    PLoS One. 2017;12:e0173294.
    PubMed     Text format     Abstract available


  63. LU W, Wan Y, Ma F, Johnson RP, et al
    Distinct transcriptome profiles of Gag-specific CD8+ T cells temporally correlated with the protection elicited by SIVDeltanef live attenuated vaccine.
    PLoS One. 2017;12:e0173929.
    PubMed     Text format     Abstract available


  64. PEREIRA SR, Pereira R, Figueiredo I, Freitas V, et al
    Comparison of anti-inflammatory activities of an anthocyanin-rich fraction from Portuguese blueberries (Vaccinium corymbosum L.) and 5-aminosalicylic acid in a TNBS-induced colitis rat model.
    PLoS One. 2017;12:e0174116.
    PubMed     Text format     Abstract available


  65. SALISCH NC, Vujadinovic M, van der Helm E, Spek D, et al
    Antigen capsid-display on human adenovirus 35 via pIX fusion is a potent vaccine platform.
    PLoS One. 2017;12:e0174728.
    PubMed     Text format     Abstract available


  66. KIM SH, Chen Z, Yoshida A, Paldurai A, et al
    Evaluation of fusion protein cleavage site sequences of Newcastle disease virus in genotype matched vaccines.
    PLoS One. 2017;12:e0173965.
    PubMed     Text format     Abstract available


  67. CAMARA J, Marimon JM, Cercenado E, Larrosa N, et al
    Decrease of invasive pneumococcal disease (IPD) in adults after introduction of pneumococcal 13-valent conjugate vaccine in Spain.
    PLoS One. 2017;12:e0175224.
    PubMed     Text format     Abstract available


  68. LEE JY, Chang J
    Universal vaccine against respiratory syncytial virus A and B subtypes.
    PLoS One. 2017;12:e0175384.
    PubMed     Text format     Abstract available


  69. HAUKE CA, Taylor RK
    Production of putative enhanced oral cholera vaccine strains that express toxin-coregulated pilus.
    PLoS One. 2017;12:e0175170.
    PubMed     Text format     Abstract available


  70. SHIM E
    Cost-effectiveness of dengue vaccination in Yucatan, Mexico using a dynamic dengue transmission model.
    PLoS One. 2017;12:e0175020.
    PubMed     Text format     Abstract available


  71. VERMA S, Soto J, Vasudevan A, Schmeisser F, et al
    Determination of influenza B identity and potency in quadrivalent inactivated influenza vaccines using lineage-specific monoclonal antibodies.
    PLoS One. 2017;12:e0175733.
    PubMed     Text format     Abstract available


  72. GASPARINHO C, Piedade J, Mirante MC, Mendes C, et al
    Characterization of rotavirus infection in children with acute gastroenteritis in Bengo province, Northwestern Angola, prior to vaccine introduction.
    PLoS One. 2017;12:e0176046.
    PubMed     Text format     Abstract available


  73. GRANDAHL M, Larsson M, Tyden T, Stenhammar C, et al
    School nurses' attitudes towards and experiences of the Swedish school-based HPV vaccination programme - A repeated cross sectional study.
    PLoS One. 2017;12:e0175883.
    PubMed     Text format     Abstract available


  74. KREIZINGER Z, Sulyok KM, Grozner D, Beko K, et al
    Development of mismatch amplification mutation assays for the differentiation of MS1 vaccine strain from wild-type Mycoplasma synoviae and MS-H vaccine strains.
    PLoS One. 2017;12:e0175969.
    PubMed     Text format     Abstract available


  75. BORTHWICK N, Lin Z, Akahoshi T, Llano A, et al
    Novel, in-natural-infection subdominant HIV-1 CD8+ T-cell epitopes revealed in human recipients of conserved-region T-cell vaccines.
    PLoS One. 2017;12:e0176418.
    PubMed     Text format     Abstract available


  76. DELEA TE, Weycker D, Atwood M, Neame D, et al
    Cost-effectiveness of alternate strategies for childhood immunization against meningococcal disease with monovalent and quadrivalent conjugate vaccines in Canada.
    PLoS One. 2017;12:e0175721.
    PubMed     Text format     Abstract available


  77. JACKWOOD MW, Lee DH
    Different evolutionary trajectories of vaccine-controlled and non-controlled avian infectious bronchitis viruses in commercial poultry.
    PLoS One. 2017;12:e0176709.
    PubMed     Text format     Abstract available


  78. WIJNANS L, Dodd CN, Weibel D, Sturkenboom M, et al
    Bell's palsy and influenza(H1N1)pdm09 containing vaccines: A self-controlled case series.
    PLoS One. 2017;12:e0175539.
    PubMed     Text format     Abstract available


  79. SIMOES MJ, Bettencourt C, De Paola R, Giuliani M, et al
    Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Portugal.
    PLoS One. 2017;12:e0176177.
    PubMed     Text format     Abstract available


  80. TKACHUK AP, Gushchin VA, Potapov VD, Demidenko AV, et al
    Multi-subunit BCG booster vaccine GamTBvac: Assessment of immunogenicity and protective efficacy in murine and guinea pig TB models.
    PLoS One. 2017;12:e0176784.
    PubMed     Text format     Abstract available


  81. PAULO AC, Sa-Leao R
    Periodic cycles of pneumococcal serotypes carried by children before and after 7-valent pneumococcal conjugate vaccine.
    PLoS One. 2017;12:e0176723.
    PubMed     Text format     Abstract available


  82. HEO JY, Seo YB, Choi WS, Lee J, et al
    Cost-effectiveness of pneumococcal vaccination strategies for the elderly in Korea.
    PLoS One. 2017;12:e0177342.
    PubMed     Text format     Abstract available


  83. VON REYN CF, Lahey T, Arbeit RD, Landry B, et al
    Safety and immunogenicity of an inactivated whole cell tuberculosis vaccine booster in adults primed with BCG: A randomized, controlled trial of DAR-901.
    PLoS One. 2017;12:e0175215.
    PubMed     Text format     Abstract available


  84. GILBERT PB, Excler JL, Tomaras GD, Carpp LN, et al
    Antibody to HSV gD peptide induced by vaccination does not protect against HSV-2 infection in HSV-2 seronegative women.
    PLoS One. 2017;12:e0176428.
    PubMed     Text format     Abstract available


  85. VAN AALST S, Ludwig IS, van der Zee R, van Eden W, et al
    Bystander activation of irrelevant CD4+ T cells following antigen-specific vaccination occurs in the presence and absence of adjuvant.
    PLoS One. 2017;12:e0177365.
    PubMed     Text format     Abstract available


  86. HAUSE AM, Henke DM, Avadhanula V, Shaw CA, et al
    Sequence variability of the respiratory syncytial virus (RSV) fusion gene among contemporary and historical genotypes of RSV/A and RSV/B.
    PLoS One. 2017;12:e0175792.
    PubMed     Text format     Abstract available


  87. MORTENSEN R, Christensen D, Hansen LB, Christensen JP, et al
    Local Th17/IgA immunity correlate with protection against intranasal infection with Streptococcus pyogenes.
    PLoS One. 2017;12:e0175707.
    PubMed     Text format     Abstract available


  88. TALLMADGE RL, Miller SC, Parry SA, Felippe MJB, et al
    Antigen-specific immunoglobulin variable region sequencing measures humoral immune response to vaccination in the equine neonate.
    PLoS One. 2017;12:e0177831.
    PubMed     Text format     Abstract available


  89. BALL JP, Springer MJ, Ni Y, Finger-Baker I, et al
    Intranasal delivery of a bivalent norovirus vaccine formulated in an in situ gelling dry powder.
    PLoS One. 2017;12:e0177310.
    PubMed     Text format     Abstract available


  90. HANSEN NS, Byberg S, Hervig Jacobsen L, Bjerregaard-Andersen M, et al
    Effect of early measles vaccine on pneumococcal colonization: A randomized trial from Guinea-Bissau.
    PLoS One. 2017;12:e0177547.
    PubMed     Text format     Abstract available


  91. LAI X, Friedman A
    Combination therapy of cancer with cancer vaccine and immune checkpoint inhibitors: A mathematical model.
    PLoS One. 2017;12:e0178479.
    PubMed     Text format     Abstract available


  92. IN HJ, Lim H, Lee JA, Kim HJ, et al
    An inactivated hand-foot-and-mouth disease vaccine using the enterovirus 71 (C4a) strain isolated from a Korean patient induces a strong immunogenic response in mice.
    PLoS One. 2017;12:e0178259.
    PubMed     Text format     Abstract available


  93. NOH JY, Lim S, Song JY, Choi WS, et al
    Interim estimates of the effectiveness of the influenza vaccine against A(H3N2) influenza in adults in South Korea, 2016-2017 season.
    PLoS One. 2017;12:e0178010.
    PubMed     Text format     Abstract available


  94. TIN TIN HTAR M, Stuurman AL, Ferreira G, Alicino C, et al
    Effectiveness of pneumococcal vaccines in preventing pneumonia in adults, a systematic review and meta-analyses of observational studies.
    PLoS One. 2017;12:e0177985.
    PubMed     Text format     Abstract available


  95. HOLINKA LG, O'Donnell V, Risatti GR, Azzinaro P, et al
    Early protection events in swine immunized with an experimental live attenuated classical swine fever marker vaccine, FlagT4G.
    PLoS One. 2017;12:e0177433.
    PubMed     Text format     Abstract available


  96. NYIRO JU, Kombe IK, Sande CJ, Kipkoech J, et al
    Defining the vaccination window for respiratory syncytial virus (RSV) using age-seroprevalence data for children in Kilifi, Kenya.
    PLoS One. 2017;12:e0177803.
    PubMed     Text format     Abstract available


  97. DESCLOZEAUX M, Robbins A, Jelocnik M, Khan SA, et al
    Immunization of a wild koala population with a recombinant Chlamydia pecorum Major Outer Membrane Protein (MOMP) or Polymorphic Membrane Protein (PMP) based vaccine: New insights into immune response, protection and clearance.
    PLoS One. 2017;12:e0178786.
    PubMed     Text format     Abstract available


  98. GALLAGHER KE, Howard N, Kabakama S, Mounier-Jack S, et al
    Lessons learnt from human papillomavirus (HPV) vaccination in 45 low- and middle-income countries.
    PLoS One. 2017;12:e0177773.
    PubMed     Text format     Abstract available


  99. WAGNER AL, Mubarak MY, Johnson LE, Porth JM, et al
    Trends of vaccine-preventable diseases in Afghanistan from the Disease Early Warning System, 2009-2015.
    PLoS One. 2017;12:e0178677.
    PubMed     Text format     Abstract available


  100. PAIS R, Omosun Y, He Q, Blas-Machado U, et al
    Rectal administration of a chlamydial subunit vaccine protects against genital infection and upper reproductive tract pathology in mice.
    PLoS One. 2017;12:e0178537.
    PubMed     Text format     Abstract available


  101. ZEIGLER DF, Roque R, Clegg CH
    Construction of an enantiopure bivalent nicotine vaccine using synthetic peptides.
    PLoS One. 2017;12:e0178835.
    PubMed     Text format     Abstract available


  102. CARRENO JM, Perez-Shibayama C, Gil-Cruz C, Lopez-Macias C, et al
    Evolution of Salmonella Typhi outer membrane protein-specific T and B cell responses in humans following oral Ty21a vaccination: A randomized clinical trial.
    PLoS One. 2017;12:e0178669.
    PubMed     Text format     Abstract available


  103. KAMETANI Y, Katano I, Miyamoto A, Kikuchi Y, et al
    NOG-hIL-4-Tg, a new humanized mouse model for producing tumor antigen-specific IgG antibody by peptide vaccination.
    PLoS One. 2017;12:e0179239.
    PubMed     Text format     Abstract available


  104. GHERASIM A, Martinez-Baz I, Castilla J, Pozo F, et al
    Effect of previous and current vaccination against influenza A(H1N1)pdm09, A(H3N2), and B during the post-pandemic period 2010-2016 in Spain.
    PLoS One. 2017;12:e0179160.
    PubMed     Text format     Abstract available


  105. NHANTUMBO AA, Weldegebriel G, Katsande R, de Gouveia L, et al
    Surveillance of impact of PCV-10 vaccine on pneumococcal meningitis in Mozambique, 2013 - 2015.
    PLoS One. 2017;12:e0177746.
    PubMed     Text format     Abstract available


  106. GOYEN KA, Wright JD, Cunneen A, Henning J, et al
    Playing with fire - What is influencing horse owners' decisions to not vaccinate their horses against deadly Hendra virus infection?
    PLoS One. 2017;12:e0180062.
    PubMed     Text format     Abstract available


  107. WANG Y, Li J, Xiong K, Chen Z, et al
    Elimination of persistent vaccine bacteria of Salmonella enterica serovar Typhimurium in the guts of immunized mice by inducible expression of truncated YncE.
    PLoS One. 2017;12:e0179649.
    PubMed     Text format     Abstract available


  108. WEIR GM, Karkada M, Hoskin D, Stanford MM, et al
    Combination of poly I:C and Pam3CSK4 enhances activation of B cells in vitro and boosts antibody responses to protein vaccines in vivo.
    PLoS One. 2017;12:e0180073.
    PubMed     Text format     Abstract available


  109. DE WOLF ACMT, van Aalst S, Ludwig IS, Bodinham CL, et al
    Regulatory T cell frequencies and phenotypes following anti-viral vaccination.
    PLoS One. 2017;12:e0179942.
    PubMed     Text format     Abstract available


  110. ELLIS CK, Rice S, Maurer D, Stahl R, et al
    Use of fecal volatile organic compound analysis to discriminate between non-vaccinated and BCG-Vaccinated cattle prior to and after Mycobacterium bovis challenge.
    PLoS One. 2017;12:e0179914.
    PubMed     Text format     Abstract available


  111. MATYUSHENKO V, Isakova-Sivak I, Smolonogina T, Dubrovina I, et al
    Genotyping assay for differentiation of wild-type and vaccine viruses in subjects immunized with live attenuated influenza vaccine.
    PLoS One. 2017;12:e0180497.
    PubMed     Text format     Abstract available


  112. MUKHERJEE S, Subramaniam R, Chen H, Smith A, et al
    Boosting efferocytosis in alveolar space using BCG vaccine to protect host against influenza pneumonia.
    PLoS One. 2017;12:e0180143.
    PubMed     Text format     Abstract available


  113. BALSEIRO A, Altuzarra R, Vidal E, Moll X, et al
    Assessment of BCG and inactivated Mycobacterium bovis vaccines in an experimental tuberculosis infection model in sheep.
    PLoS One. 2017;12:e0180546.
    PubMed     Text format     Abstract available


  114. VON MOLLENDORF C, Tempia S, von Gottberg A, Meiring S, et al
    Estimated severe pneumococcal disease cases and deaths before and after pneumococcal conjugate vaccine introduction in children younger than 5 years of age in South Africa.
    PLoS One. 2017;12:e0179905.
    PubMed     Text format     Abstract available


  115. REAVIS RD, Ebbs JB, Onunkwo AK, Sage LM, et al
    A self-affirmation exercise does not improve intentions to vaccinate among parents with negative vaccine attitudes (and may decrease intentions to vaccinate).
    PLoS One. 2017;12:e0181368.
    PubMed     Text format     Abstract available


  116. STERVBO U, Pohlmann D, Baron U, Bozzetti C, et al
    Age dependent differences in the kinetics of gammadelta T cells after influenza vaccination.
    PLoS One. 2017;12:e0181161.
    PubMed     Text format     Abstract available


  117. SABOL I, Milutin Gasperov N, Matovina M, Bozinovic K, et al
    Cervical HPV type-specific pre-vaccination prevalence and age distribution in Croatia.
    PLoS One. 2017;12:e0180480.
    PubMed     Text format     Abstract available


  118. BUCHBINDER SP, Grunenberg NA, Sanchez BJ, Seaton KE, et al
    Immunogenicity of a novel Clade B HIV-1 vaccine combination: Results of phase 1 randomized placebo controlled trial of an HIV-1 GM-CSF-expressing DNA prime with a modified vaccinia Ankara vaccine boost in healthy HIV-1 uninfected adults.
    PLoS One. 2017;12:e0179597.
    PubMed     Text format     Abstract available


  119. LORENZO MM, Sanchez-Puig JM, Blasco R
    Vaccinia virus and Cowpox virus are not susceptible to the interferon-induced antiviral protein MxA.
    PLoS One. 2017;12:e0181459.
    PubMed     Text format     Abstract available


  120. RICHARDSON S, Seekaew P, Koblin B, Vazquez T, et al
    Barriers and facilitators of HIV vaccine and prevention study participation among Young Black MSM and transwomen in New York City.
    PLoS One. 2017;12:e0181702.
    PubMed     Text format     Abstract available


  121. TIEN SH, Crabtree JN, Gray HL, Peterson EJ, et al
    Immunologic response to vaccine challenge in pregnant PTPN22 R620W carriers and non-carriers.
    PLoS One. 2017;12:e0181338.
    PubMed     Text format     Abstract available


  122. MOYO N, Borthwick NJ, Wee EG, Capucci S, et al
    Long-term follow up of human T-cell responses to conserved HIV-1 regions elicited by DNA/simian adenovirus/MVA vaccine regimens.
    PLoS One. 2017;12:e0181382.
    PubMed     Text format     Abstract available


  123. CARPENTIER AF, Geinguenaud F, Tran T, Sejalon F, et al
    Synthetic melanin bound to subunit vaccine antigens significantly enhances CD8+ T-cell responses.
    PLoS One. 2017;12:e0181403.
    PubMed     Text format     Abstract available


  124. VANDERDRIFT LE, Vanable PA, Bonafide KE, Brown JL, et al
    Using actor-partner interdependence modeling to understand HPV vaccine acceptance.
    PLoS One. 2017;12:e0181662.
    PubMed     Text format     Abstract available


  125. PLUVIANO S, Watt C, Della Sala S
    Misinformation lingers in memory: Failure of three pro-vaccination strategies.
    PLoS One. 2017;12:e0181640.
    PubMed     Text format     Abstract available


  126. XU L, Qin Y, Yang J, Han W, et al
    Coverage and factors associated with influenza vaccination among kindergarten children 2-7 years old in a low-income city of north-western China (2014-2016).
    PLoS One. 2017;12:e0181539.
    PubMed     Text format     Abstract available


  127. MARINI A, Rossi O, Aruta MG, Micoli F, et al
    Contribution of factor H-Binding protein sequence to the cross-reactivity of meningococcal native outer membrane vesicle vaccines with over-expressed fHbp variant group 1.
    PLoS One. 2017;12:e0181508.
    PubMed     Text format     Abstract available


  128. MYLLYMAKI H, Niskanen M, Oksanen KE, Sherwood E, et al
    Identification of novel antigen candidates for a tuberculosis vaccine in the adult zebrafish (Danio rerio).
    PLoS One. 2017;12:e0181942.
    PubMed     Text format     Abstract available


  129. ZHAO D, Sun B, Sun S, Fu B, et al
    Characterization of human enterovirus71 virus-like particles used for vaccine antigens.
    PLoS One. 2017;12:e0181182.
    PubMed     Text format     Abstract available


  130. TAN WG, Zubkova I, Kachko A, Wells F, et al
    Qualitative differences in cellular immunogenicity elicited by hepatitis C virus T-Cell vaccines employing prime-boost regimens.
    PLoS One. 2017;12:e0181578.
    PubMed     Text format     Abstract available


  131. FLOREK NW, Kamlangdee A, Mutschler JP, Kingstad-Bakke B, et al
    A modified vaccinia Ankara vaccine vector expressing a mosaic H5 hemagglutinin reduces viral shedding in rhesus macaques.
    PLoS One. 2017;12:e0181738.
    PubMed     Text format     Abstract available


  132. HANDY LK, Maroudi S, Powell M, Nfila B, et al
    The impact of access to immunization information on vaccine acceptance in three countries.
    PLoS One. 2017;12:e0180759.
    PubMed     Text format     Abstract available


  133. BLAGDEN S, Seddon D, Hungerford D, Stanistreet D, et al
    Uptake of a new meningitis vaccination programme amongst first-year undergraduate students in the United Kingdom: A cross-sectional study.
    PLoS One. 2017;12:e0181817.
    PubMed     Text format     Abstract available


  134. PAHIL S, Taneja N, Ansari HR, Raghava GPS, et al
    In silico analysis to identify vaccine candidates common to multiple serotypes of Shigella and evaluation of their immunogenicity.
    PLoS One. 2017;12:e0180505.
    PubMed     Text format     Abstract available


  135. LI M, Cai RJ, Li CL, Song S, et al
    Deletion of ssnA Attenuates the Pathogenicity of Streptococcus suis and Confers Protection against Serovar 2 Strain Challenge.
    PLoS One. 2017;12:e0169791.
    PubMed     Text format     Abstract available


  136. YANEZ RJR, Lamprecht R, Granadillo M, Weber B, et al
    Expression optimization of a cell membrane-penetrating human papillomavirus type 16 therapeutic vaccine candidate in Nicotiana benthamiana.
    PLoS One. 2017;12:e0183177.
    PubMed     Text format     Abstract available


  137. DOUCET M, El-Turabi A, Zabel F, Hunn BHM, et al
    Preclinical development of a vaccine against oligomeric alpha-synuclein based on virus-like particles.
    PLoS One. 2017;12:e0181844.
    PubMed     Text format     Abstract available


  138. HASERICK JR, Klein JA, Costello CE, Samuelson J, et al
    Cryptosporidium parvum vaccine candidates are incompletely modified with O-linked-N-acetylgalactosamine or contain N-terminal N-myristate and S-palmitate.
    PLoS One. 2017;12:e0182395.
    PubMed     Text format     Abstract available


  139. CHEN WA, Zhang J, Hall KM, Martin CB, et al
    Addition of alphaGal HyperAcute technology to recombinant avian influenza vaccines induces strong low-dose antibody responses.
    PLoS One. 2017;12:e0182683.
    PubMed     Text format     Abstract available


  140. PATEL P, Bharti PK, Bansal D, Raman RK, et al
    Genetic diversity and antibody responses against Plasmodium falciparum vaccine candidate genes from Chhattisgarh, Central India: Implication for vaccine development.
    PLoS One. 2017;12:e0182674.
    PubMed     Text format     Abstract available


  141. BARNARD M, George P, Perryman ML, Wolff LA, et al
    Human papillomavirus (HPV) vaccine knowledge, attitudes, and uptake in college students: Implications from the Precaution Adoption Process Model.
    PLoS One. 2017;12:e0182266.
    PubMed     Text format     Abstract available


  142. OUSMANE S, Diallo BA, Ouedraogo R, Sanda AA, et al
    Serotype Distribution and Antimicrobial Sensitivity Profile of Streptococcus pneumoniae Carried in Healthy Toddlers before PCV13 Introduction in Niamey, Niger.
    PLoS One. 2017;12:e0169547.
    PubMed     Text format     Abstract available


  143. HOVINGH ES, van Gent M, Hamstra HJ, Demkes M, et al
    Emerging Bordetella pertussis Strains Induce Enhanced Signaling of Human Pattern Recognition Receptors TLR2, NOD2 and Secretion of IL-10 by Dendritic Cells.
    PLoS One. 2017;12:e0170027.
    PubMed     Text format     Abstract available


  144. HANSEN EDWARDS C, de Blasio BF, Salamanca BV, Flem E, et al
    Re-evaluation of the cost-effectiveness and effects of childhood rotavirus vaccination in Norway.
    PLoS One. 2017;12:e0183306.
    PubMed     Text format     Abstract available


  145. BECKER-DREPS S, Blette B, Briceno R, Aleman J, et al
    Changes in the incidence of pneumonia, bacterial meningitis, and infant mortality 5 years following introduction of the 13-valent pneumococcal conjugate vaccine in a "3+0" schedule.
    PLoS One. 2017;12:e0183348.
    PubMed     Text format     Abstract available


  146. CHIUPPESI F, Wussow F, Scharf L, Contreras H, et al
    Comparison of homologous and heterologous prime-boost vaccine approaches using Modified Vaccinia Ankara and soluble protein to induce neutralizing antibodies by the human cytomegalovirus pentamer complex in mice.
    PLoS One. 2017;12:e0183377.
    PubMed     Text format     Abstract available


  147. DOMINGUEZ A, Ciruela P, Hernandez S, Garcia-Garcia JJ, et al
    Effectiveness of the 13-valent pneumococcal conjugate vaccine in preventing invasive pneumococcal disease in children aged 7-59 months. A matched case-control study.
    PLoS One. 2017;12:e0183191.
    PubMed     Text format     Abstract available


  148. OONG XY, Ng KT, Tan JL, Chan KG, et al
    Whole-Genome Phylogenetic Analysis of Influenza B/Phuket/3073/2013-Like Viruses and Unique Reassortants Detected in Malaysia between 2012 and 2014.
    PLoS One. 2017;12:e0170610.
    PubMed     Text format     Abstract available


  149. KORENROMP EL, Wi T, Resch S, Stover J, et al
    Costing of National STI Program Implementation for the Global STI Control Strategy for the Health Sector, 2016-2021.
    PLoS One. 2017;12:e0170773.
    PubMed     Text format     Abstract available


  150. LOKHANDWALA S, Fang X, Waghela SD, Bray J, et al
    Priming Cross-Protective Bovine Viral Diarrhea Virus-Specific Immunity Using Live-Vectored Mosaic Antigens.
    PLoS One. 2017;12:e0170425.
    PubMed     Text format     Abstract available


  151. ZHANG A, Wang D, Li J, Gao F, et al
    The effect of aqueous extract of Xinjiang Artemisia rupestris L. (an influenza virus vaccine adjuvant) on enhancing immune responses and reducing antigen dose required for immunity.
    PLoS One. 2017;12:e0183720.
    PubMed     Text format     Abstract available


  152. BODSON J, Wilson A, Warner EL, Kepka D, et al
    Religion and HPV vaccine-related awareness, knowledge, and receipt among insured women aged 18-26 in Utah.
    PLoS One. 2017;12:e0183725.
    PubMed     Text format     Abstract available


  153. CALAZANS A, Boggiano C, Lindsay R
    A DNA inducing VLP vaccine designed for HIV and tested in mice.
    PLoS One. 2017;12:e0183803.
    PubMed     Text format     Abstract available


  154. WEISSMUELLER NT, Marsay L, Schiffter HA, Carlisle RC, et al
    Alternative vaccine administration by powder injection: Needle-free dermal delivery of the glycoconjugate meningococcal group Y vaccine.
    PLoS One. 2017;12:e0183427.
    PubMed     Text format     Abstract available


  155. VAN GOOR A, Stromberg ZR, Mellata M
    A recombinant multi-antigen vaccine with broad protection potential against avian pathogenic Escherichia coli.
    PLoS One. 2017;12:e0183929.
    PubMed     Text format     Abstract available


  156. KITTIKRAISAK W, Suntarattiwong P, Ditsungnoen D, Pallas SE, et al
    Cost-effectiveness of inactivated seasonal influenza vaccination in a cohort of Thai children </=60 months of age.
    PLoS One. 2017;12:e0183391.
    PubMed     Text format     Abstract available


  157. TAPIA F, Jordan I, Genzel Y, Reichl U, et al
    Efficient and stable production of Modified Vaccinia Ankara virus in two-stage semi-continuous and in continuous stirred tank cultivation systems.
    PLoS One. 2017;12:e0182553.
    PubMed     Text format     Abstract available


  158. KUO CF, Tsao N, Hsieh IC, Lin YS, et al
    Immunization with a streptococcal multiple-epitope recombinant protein protects mice against invasive group A streptococcal infection.
    PLoS One. 2017;12:e0174464.
    PubMed     Text format     Abstract available


  159. KELLY HA, Ngou J, Chikandiwa A, Sawadogo B, et al
    Associations of Human Papillomavirus (HPV) genotypes with high-grade cervical neoplasia (CIN2+) in a cohort of women living with HIV in Burkina Faso and South Africa.
    PLoS One. 2017;12:e0174117.
    PubMed     Text format     Abstract available


  160. MORSICA G, Bagaglio S, Spagnuolo V, Castagna A, et al
    Immune response to hepatitis B vaccination in HIV-positive individuals with isolated antibodies against hepatitis B core antigen: Results of a prospective Italian study.
    PLoS One. 2017;12:e0184128.
    PubMed     Text format     Abstract available


  161. LIU H, Shen W, Shu J, Kou Z, et al
    A novel polyepitope vaccine elicited HIV peptide specific CD4+ T cell responses in HLA-A2/DRB1 transgenic mice.
    PLoS One. 2017;12:e0184207.
    PubMed     Text format     Abstract available


  162. COMSTEDT P, Schuler W, Meinke A, Lundberg U, et al
    The novel Lyme borreliosis vaccine VLA15 shows broad protection against Borrelia species expressing six different OspA serotypes.
    PLoS One. 2017;12:e0184357.
    PubMed     Text format     Abstract available


  163. AMES H, Njang DM, Glenton C, Fretheim A, et al
    Stakeholder perceptions of communication about vaccination in two regions of Cameroon: A qualitative case study.
    PLoS One. 2017;12:e0183721.
    PubMed     Text format     Abstract available


  164. HUANG HC, Singh B, Morton DP, Johnson GP, et al
    Equalizing access to pandemic influenza vaccines through optimal allocation to public health distribution points.
    PLoS One. 2017;12:e0182720.
    PubMed     Text format     Abstract available


  165. MUNOZ L, Gonzalez L, Soldevila L, Dorca J, et al
    QuantiFERON(R)-TB Gold In-Tube for contact screening in BCG-vaccinated adults: A longitudinal cohort study.
    PLoS One. 2017;12:e0183258.
    PubMed     Text format     Abstract available


  166. HUI SYA, Sahota DS, Lao TT
    Impact of the two-dose rubella vaccination regimen on incidence of rubella seronegativity in gravidae aged 25 years and younger.
    PLoS One. 2017;12:e0183630.
    PubMed     Text format     Abstract available


  167. SHEWELL LK, Jen FE, Jennings MP
    Refinement of immunizing antigens to produce functional blocking antibodies against the AniA nitrite reductase of Neisseria gonorrhoeae.
    PLoS One. 2017;12:e0182555.
    PubMed     Text format     Abstract available


  168. GONZALEZ-JUARBE N, Shen H, Bergman MA, Orihuela CJ, et al
    YopE specific CD8+ T cells provide protection against systemic and mucosal Yersinia pseudotuberculosis infection.
    PLoS One. 2017;12:e0172314.
    PubMed     Text format     Abstract available


  169. MI K, Ou X, Guo L, Ye J, et al
    Comparative analysis of the immunogenicity of monovalent and multivalent rotavirus immunogens.
    PLoS One. 2017;12:e0172156.
    PubMed     Text format     Abstract available


  170. ORENSTEIN EW, Orenstein LA, Diarra K, Djiteye M, et al
    Cost-effectiveness of maternal influenza immunization in Bamako, Mali: A decision analysis.
    PLoS One. 2017;12:e0171499.
    PubMed     Text format     Abstract available


  171. XIA J, Cui JQ, He X, Liu YY, et al
    Genetic and antigenic evolution of H9N2 subtype avian influenza virus in domestic chickens in southwestern China, 2013-2016.
    PLoS One. 2017;12:e0171564.
    PubMed     Text format     Abstract available


  172. ENDO F, Tabata T, Sadato D, Kawamura M, et al
    Development of a simple and quick immunochromatography method for detection of anti-HPV-16/-18 antibodies.
    PLoS One. 2017;12:e0171314.
    PubMed     Text format     Abstract available


  173. KROGSGAARD LW, Vestergaard CH, Plana-Ripoll O, Lutzen TH, et al
    Health care utilization in general practice after HPV vaccination-A Danish nationwide register-based cohort study.
    PLoS One. 2017;12:e0184658.
    PubMed     Text format     Abstract available


  174. ANDRADE AL, Afonso ET, Minamisava R, Bierrenbach AL, et al
    Direct and indirect impact of 10-valent pneumococcal conjugate vaccine introduction on pneumonia hospitalizations and economic burden in all age-groups in Brazil: A time-series analysis.
    PLoS One. 2017;12:e0184204.
    PubMed     Text format    


  175. NYAOKE BA, Mutua GN, Sajabi R, Nyasani D, et al
    Volunteer motivators for participating in HIV vaccine clinical trials in Nairobi, Kenya.
    PLoS One. 2017;12:e0183788.
    PubMed     Text format     Abstract available


  176. PREBENSEN C, Troseid M, Ueland T, Dahm A, et al
    Immune activation and HIV-specific T cell responses are modulated by a cyclooxygenase-2 inhibitor in untreated HIV-infected individuals: An exploratory clinical trial.
    PLoS One. 2017;12:e0176527.
    PubMed     Text format     Abstract available


  177. ABUDULAI LN, Fernandez S, Corscadden K, Burrows SA, et al
    Production of IgG antibodies to pneumococcal polysaccharides is associated with expansion of ICOS+ circulating memory T follicular-helper cells which is impaired by HIV infection.
    PLoS One. 2017;12:e0176641.
    PubMed     Text format     Abstract available


  178. ZENG Y, Liu B, Rubio MT, Wang X, et al
    Creation of an immunodeficient HLA-transgenic mouse (HUMAMICE) and functional validation of human immunity after transfer of HLA-matched human cells.
    PLoS One. 2017;12:e0173754.
    PubMed     Text format     Abstract available


  179. JIA B, McNeil LK, Dupont CD, Tsioris K, et al
    Longitudinal multiparameter single-cell analysis of macaques immunized with pneumococcal protein-conjugated or unconjugated polysaccharide vaccines reveals distinct antigen specific memory B cell repertoires.
    PLoS One. 2017;12:e0183738.
    PubMed     Text format     Abstract available


  180. KANEKO M, Takanashi S, Thongprachum A, Hanaoka N, et al
    Identification of vaccine-derived rotavirus strains in children with acute gastroenteritis in Japan, 2012-2015.
    PLoS One. 2017;12:e0184067.
    PubMed     Text format     Abstract available


  181. ALAM S, Chan C, Qiu X, Shannon I, et al
    Selective pre-priming of HA-specific CD4 T cells restores immunological reactivity to HA on heterosubtypic influenza infection.
    PLoS One. 2017;12:e0176407.
    PubMed     Text format     Abstract available


  182. LY HJ, Lokugamage N, Nishiyama S, Ikegami T, et al
    Risk analysis of inter-species reassortment through a Rift Valley fever phlebovirus MP-12 vaccine strain.
    PLoS One. 2017;12:e0185194.
    PubMed     Text format     Abstract available


  183. FRAIBERK M, Hajkova M, Krulova M, Kojzarova M, et al
    Exploitation of stable nanostructures based on the mouse polyomavirus for development of a recombinant vaccine against porcine circovirus 2.
    PLoS One. 2017;12:e0184870.
    PubMed     Text format     Abstract available


  184. LUEDERS I, Young D, Maree L, van der Horst G, et al
    Effects of GnRH vaccination in wild and captive African Elephant bulls (Loxodonta africana) on reproductive organs and semen quality.
    PLoS One. 2017;12:e0178270.
    PubMed     Text format     Abstract available


  185. EVANGELISTA KV, Lourdault K, Matsunaga J, Haake DA, et al
    Immunoprotective properties of recombinant LigA and LigB in a hamster model of acute leptospirosis.
    PLoS One. 2017;12:e0180004.
    PubMed     Text format     Abstract available


  186. KAR R, Nangpal P, Mathur S, Singh S, et al
    bioA mutant of Mycobacterium tuberculosis shows severe growth defect and imparts protection against tuberculosis in guinea pigs.
    PLoS One. 2017;12:e0179513.
    PubMed     Text format     Abstract available


  187. OSTENSSON E, Silfverschiold M, Greiff L, Asciutto C, et al
    The economic burden of human papillomavirus-related precancers and cancers in Sweden.
    PLoS One. 2017;12:e0179520.
    PubMed     Text format     Abstract available


  188. SARTORI AL, Minamisava R, Bierrenbach AL, Toscano CM, et al
    Reduction in all-cause otitis media-related outpatient visits in children after PCV10 introduction in Brazil.
    PLoS One. 2017;12:e0179222.
    PubMed     Text format     Abstract available


  189. PIPKINS HR, Bradshaw JL, Keller LE, Swiatlo E, et al
    Polyamine transporter potABCD is required for virulence of encapsulated but not nonencapsulated Streptococcus pneumoniae.
    PLoS One. 2017;12:e0179159.
    PubMed     Text format     Abstract available


  190. BYBERG S, Ostergaard MD, Rodrigues A, Martins C, et al
    Analysis of risk factors for infant mortality in the 1992-3 and 2002-3 birth cohorts in rural Guinea-Bissau.
    PLoS One. 2017;12:e0177984.
    PubMed     Text format     Abstract available


  191. WANG G, Yin R, Zhou P, Ding Z, et al
    Combination of the immunization with the sequence close to the consensus sequence and two DNA prime plus one VLP boost generate H5 hemagglutinin specific broad neutralizing antibodies.
    PLoS One. 2017;12:e0176854.
    PubMed     Text format     Abstract available


  192. VINOD N, Noh HB, Oh S, Ji S, et al
    A Salmonella typhimurium ghost vaccine induces cytokine expression in vitro and immune responses in vivo and protects rats against homologous and heterologous challenges.
    PLoS One. 2017;12:e0185488.
    PubMed     Text format     Abstract available


  193. FABURAY B, McGill J, Jongejan F
    A glycosylated recombinant subunit candidate vaccine consisting of Ehrlichia ruminantium major antigenic protein1 induces specific humoral and Th1 type cell responses in sheep.
    PLoS One. 2017;12:e0185495.
    PubMed     Text format     Abstract available


  194. GRIMALDI G JR, Teva A, Dos-Santos CB, Santos FN, et al
    Field trial of efficacy of the Leish-tec(R) vaccine against canine leishmaniasis caused by Leishmania infantum in an endemic area with high transmission rates.
    PLoS One. 2017;12:e0185438.
    PubMed     Text format     Abstract available


  195. ROSAS-UMBERT M, Mothe B, Noguera-Julian M, Bellido R, et al
    Virological and immunological outcome of treatment interruption in HIV-1-infected subjects vaccinated with MVA-B.
    PLoS One. 2017;12:e0184929.
    PubMed     Text format     Abstract available


  196. SHIN HJ, Franco LH, Nair VR, Collins AC, et al
    A baculovirus-conjugated mimotope vaccine targeting Mycobacterium tuberculosis lipoarabinomannan.
    PLoS One. 2017;12:e0185945.
    PubMed     Text format     Abstract available


  197. SCHMID BC, Carlson J, Rezniczek GA, Wyllie J, et al
    Examining word association networks: A cross-country comparison of women's perceptions of HPV testing and vaccination.
    PLoS One. 2017;12:e0185669.
    PubMed     Text format     Abstract available


  198. HSU AP, Tseng CH, Barrat J, Lee SH, et al
    Safety, efficacy and immunogenicity evaluation of the SAG2 oral rabies vaccine in Formosan ferret badgers.
    PLoS One. 2017;12:e0184831.
    PubMed     Text format     Abstract available


  199. CAPUCCI S, Wee EG, Schiffner T, LaBranche CC, et al
    HIV-1-neutralizing antibody induced by simian adenovirus- and poxvirus MVA-vectored BG505 native-like envelope trimers.
    PLoS One. 2017;12:e0181886.
    PubMed     Text format     Abstract available


  200. CHOTUN N, Preiser W, van Rensburg CJ, Fernandez P, et al
    Point-of-care screening for hepatitis B virus infection in pregnant women at an antenatal clinic: A South African experience.
    PLoS One. 2017;12:e0181267.
    PubMed     Text format     Abstract available


  201. PEREZ LG, Martinez DR, deCamp AC, Pinter A, et al
    V1V2-specific complement activating serum IgG as a correlate of reduced HIV-1 infection risk in RV144.
    PLoS One. 2017;12:e0180720.
    PubMed     Text format     Abstract available


  202. MINAYA MA, Korom M, Wang H, Belshe RB, et al
    The herpevac trial for women: Sequence analysis of glycoproteins from viruses obtained from infected subjects.
    PLoS One. 2017;12:e0176687.
    PubMed     Text format     Abstract available


  203. HASSAN AO, Amen O, Sayedahmed EE, Vemula SV, et al
    Adenovirus vector-based multi-epitope vaccine provides partial protection against H5, H7, and H9 avian influenza viruses.
    PLoS One. 2017;12:e0186244.
    PubMed     Text format     Abstract available


  204. FERREYRA-REYES L, Cruz-Hervert LP, Troy SB, Huang C, et al
    Assessing the individual risk of fecal poliovirus shedding among vaccinated and non-vaccinated subjects following national health weeks in Mexico.
    PLoS One. 2017;12:e0185594.
    PubMed     Text format     Abstract available


  205. MAILYBAYEVA A, Yespembetov B, Ryskeldinova S, Zinina N, et al
    Improved influenza viral vector based Brucella abortus vaccine induces robust B and T-cell responses and protection against Brucella melitensis infection in pregnant sheep and goats.
    PLoS One. 2017;12:e0186484.
    PubMed     Text format     Abstract available


  206. WARD PR, Attwell K, Meyer SB, Rokkas P, et al
    Understanding the perceived logic of care by vaccine-hesitant and vaccine-refusing parents: A qualitative study in Australia.
    PLoS One. 2017;12:e0185955.
    PubMed     Text format     Abstract available


  207. BILLARD MN, De Serres G, Gariepy MC, Boulianne N, et al
    Prevalence of risk factors for acquiring measles during the 2011 outbreak in Quebec and impact of the province-wide school-based vaccination campaign on population immunity.
    PLoS One. 2017;12:e0186070.
    PubMed     Text format     Abstract available


  208. MCCURLEY NP, Domi A, Basu R, Saunders KO, et al
    HIV transmitted/founder vaccines elicit autologous tier 2 neutralizing antibodies for the CD4 binding site.
    PLoS One. 2017;12:e0177863.
    PubMed     Text format     Abstract available


  209. SMITH SG, Harris SA, Satti I, Bryan D, et al
    Assay optimisation and technology transfer for multi-site immuno-monitoring in vaccine trials.
    PLoS One. 2017;12:e0184391.
    PubMed     Text format     Abstract available


  210. BOTWRIGHT S, Holroyd T, Nanda S, Bloem P, et al
    Experiences of operational costs of HPV vaccine delivery strategies in Gavi-supported demonstration projects.
    PLoS One. 2017;12:e0182663.
    PubMed     Text format     Abstract available


  211. GIANINO MM, Politano G, Scarmozzino A, Charrier L, et al
    Estimation of sickness absenteeism among Italian healthcare workers during seasonal influenza epidemics.
    PLoS One. 2017;12:e0182510.
    PubMed     Text format     Abstract available


  212. RAZAZAN A, Behravan J, Arab A, Barati N, et al
    Conjugated nanoliposome with the HER2/neu-derived peptide GP2 as an effective vaccine against breast cancer in mice xenograft model.
    PLoS One. 2017;12:e0185099.
    PubMed     Text format     Abstract available


  213. CHEN SI
    Economic benefits of sharing and redistributing influenza vaccines when shortages occurred.
    PLoS One. 2017;12:e0186418.
    PubMed     Text format     Abstract available


  214. LEE YL, Lin KY, Cheng CY, Li CW, et al
    Evolution of hepatitis A virus seroprevalence among HIV-positive adults in Taiwan.
    PLoS One. 2017;12:e0186338.
    PubMed     Text format     Abstract available


  215. HIGGINS JL, Gonzalez-Juarrero M, Bowen RA
    Evaluation of shedding, tissue burdens, and humoral immune response in goats after experimental challenge with the virulent Brucella melitensis strain 16M and the reduced virulence vaccine strain Rev. 1.
    PLoS One. 2017;12:e0185823.
    PubMed     Text format     Abstract available


  216. VAN DEN BIGGELAAR AHJ, Richmond PC, Fuery A, Anderson D, et al
    Pneumococcal responses are similar in Papua New Guinean children aged 3-5 years vaccinated in infancy with pneumococcal polysaccharide vaccine with or without prior pneumococcal conjugate vaccine, or without pneumococcal vaccination.
    PLoS One. 2017;12:e0185877.
    PubMed     Text format     Abstract available


  217. DOWELL AC, Cobby E, Wen K, Devall AJ, et al
    Interleukin-17-positive mast cells influence outcomes from BCG for patients with CIS: Data from a comprehensive characterisation of the immune microenvironment of urothelial bladder cancer.
    PLoS One. 2017;12:e0184841.
    PubMed     Text format     Abstract available


  218. CLARK A, Black R, Tate J, Roose A, et al
    Estimating global, regional and national rotavirus deaths in children aged <5 years: Current approaches, new analyses and proposed improvements.
    PLoS One. 2017;12:e0183392.
    PubMed     Text format     Abstract available


  219. TI J, Li Z, Li X, Lu Y, et al
    Identification of one B-cell epitope from NS1 protein of duck Tembusu virus with monoclonal antibodies.
    PLoS One. 2017;12:e0181177.
    PubMed     Text format     Abstract available


  220. C GUARDO A, Gomez CE, Diaz-Brito V, Pich J, et al
    Safety and vaccine-induced HIV-1 immune responses in healthy volunteers following a late MVA-B boost 4 years after the last immunization.
    PLoS One. 2017;12:e0186602.
    PubMed     Text format     Abstract available


  221. KAZADI EK, Tshilenge GM, Mbao V, Njoumemi Z, et al
    Determinants of dog owner-charged rabies vaccination in Kinshasa, Democratic Republic of Congo.
    PLoS One. 2017;12:e0186677.
    PubMed     Text format     Abstract available


  222. MONAMELE GC, Vernet MA, Njankouo MR, Victoir K, et al
    Genetic and antigenic characterization of influenza A(H3N2) in Cameroon during the 2014-2016 influenza seasons.
    PLoS One. 2017;12:e0184411.
    PubMed     Text format     Abstract available


  223. SABET S, George MA, El-Shorbagy HM, Bassiony H, et al
    Gelatin nanoparticles enhance delivery of hepatitis C virus recombinant NS2 gene.
    PLoS One. 2017;12:e0181723.
    PubMed     Text format     Abstract available


  224. ROSE J, Homa L, Meropol SB, Debanne SM, et al
    Health impact and cost-effectiveness of a domestically-produced rotavirus vaccine in India: A model based analysis.
    PLoS One. 2017;12:e0187446.
    PubMed     Text format     Abstract available


  225. GRANDAHL M, Larsson M, Dalianis T, Stenhammar C, et al
    Catch-up HPV vaccination status of adolescents in relation to socioeconomic factors, individual beliefs and sexual behaviour.
    PLoS One. 2017;12:e0187193.
    PubMed     Text format     Abstract available


  226. DIALLO AO, Soeters HM, Yameogo I, Sawadogo G, et al
    Bacterial meningitis epidemiology and return of Neisseria meningitidis serogroup A cases in Burkina Faso in the five years following MenAfriVac mass vaccination campaign.
    PLoS One. 2017;12:e0187466.
    PubMed     Text format     Abstract available


  227. ABIR T, Ogbo FA, Stevens GJ, Page AN, et al
    The impact of antenatal care, iron-folic acid supplementation and tetanus toxoid vaccination during pregnancy on child mortality in Bangladesh.
    PLoS One. 2017;12:e0187090.
    PubMed     Text format     Abstract available


  228. NUNEZ IA, Carlock MA, Allen JD, Owino SO, et al
    Impact of age and pre-existing influenza immune responses in humans receiving split inactivated influenza vaccine on the induction of the breadth of antibodies to influenza A strains.
    PLoS One. 2017;12:e0185666.
    PubMed     Text format     Abstract available


  229. CAFIERO-FONSECA ET, Stawasz A, Johnson ST, Sato R, et al
    The full benefits of adult pneumococcal vaccination: A systematic review.
    PLoS One. 2017;12:e0186903.
    PubMed     Text format     Abstract available


  230. CIONCADA R, Maddaluno M, Vo HTM, Woodruff M, et al
    Vaccine adjuvant MF59 promotes the intranodal differentiation of antigen-loaded and activated monocyte-derived dendritic cells.
    PLoS One. 2017;12:e0185843.
    PubMed     Text format     Abstract available


  231. FURUKAWA K, Tanemura M, Miyoshi E, Eguchi H, et al
    A practical approach to pancreatic cancer immunotherapy using resected tumor lysate vaccines processed to express alpha-gal epitopes.
    PLoS One. 2017;12:e0184901.
    PubMed     Text format     Abstract available


  232. SASTRY M, Zhang B, Chen M, Joyce MG, et al
    Adjuvants and the vaccine response to the DS-Cav1-stabilized fusion glycoprotein of respiratory syncytial virus.
    PLoS One. 2017;12:e0186854.
    PubMed     Text format     Abstract available


  233. LI H, Nykoluk M, Li L, Liu LR, et al
    Natural and cross-inducible anti-SIV antibodies in Mauritian cynomolgus macaques.
    PLoS One. 2017;12:e0186079.
    PubMed     Text format     Abstract available


  234. FABIANI M, Ferrante G, Minardi V, Giambi C, et al
    Comparison of rubella immunization rates in immigrant and Italian women of childbearing age: Results from the Italian behavioral surveillance system PASSI (2011-2015).
    PLoS One. 2017;12:e0178122.
    PubMed     Text format     Abstract available


  235. SORIA I, Quattrocchi V, Langellotti C, Gammella M, et al
    Dendrimeric peptides can confer protection against foot-and-mouth disease virus in cattle.
    PLoS One. 2017;12:e0185184.
    PubMed     Text format     Abstract available


  236. YOSHIOKA N, Deguchi M, Hagiya H, Kagita M, et al
    Durability of immunity by hepatitis B vaccine in Japanese health care workers depends on primary response titers and durations.
    PLoS One. 2017;12:e0187661.
    PubMed     Text format     Abstract available


  237. SAMIAK L, Emeto TI
    Vaccination and nutritional status of children in Karawari, East Sepik Province, Papua New Guinea.
    PLoS One. 2017;12:e0187796.
    PubMed     Text format     Abstract available


  238. ALVAREZ-ZUZEK LG, La Rocca CE, Iglesias JR, Braunstein LA, et al
    Epidemic spreading in multiplex networks influenced by opinion exchanges on vaccination.
    PLoS One. 2017;12:e0186492.
    PubMed     Text format     Abstract available


  239. OKU A, Oyo-Ita A, Glenton C, Fretheim A, et al
    Perceptions and experiences of childhood vaccination communication strategies among caregivers and health workers in Nigeria: A qualitative study.
    PLoS One. 2017;12:e0186733.
    PubMed     Text format     Abstract available


  240. JAMAL SB, Hassan SS, Tiwari S, Viana MV, et al
    An integrative in-silico approach for therapeutic target identification in the human pathogen Corynebacterium diphtheriae.
    PLoS One. 2017;12:e0186401.
    PubMed     Text format     Abstract available


  241. DECAMP AC, Rolland M, Edlefsen PT, Sanders-Buell E, et al
    Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120.
    PLoS One. 2017;12:e0185959.
    PubMed     Text format     Abstract available


  242. BUCHAN SA, Chung H, Campitelli MA, Crowcroft NS, et al
    Vaccine effectiveness against laboratory-confirmed influenza hospitalizations among young children during the 2010-11 to 2013-14 influenza seasons in Ontario, Canada.
    PLoS One. 2017;12:e0187834.
    PubMed     Text format     Abstract available


  243. HARALAMBIEVA IH, Gibson MJ, Kennedy RB, Ovsyannikova IG, et al
    Characterization of rubella-specific humoral immunity following two doses of MMR vaccine using proteome microarray technology.
    PLoS One. 2017;12:e0188149.
    PubMed     Text format     Abstract available


  244. DE BRUYN J, Thomson PC, Bagnol B, Maulaga W, et al
    The chicken or the egg? Exploring bi-directional associations between Newcastle disease vaccination and village chicken flock size in rural Tanzania.
    PLoS One. 2017;12:e0188230.
    PubMed     Text format     Abstract available


  245. SOBHKHEZ M, Krasnov A, Chang CJ, Robertsen B, et al
    Transcriptome analysis of plasmid-induced genes sheds light on the role of type I IFN as adjuvant in DNA vaccine against infectious salmon anemia virus.
    PLoS One. 2017;12:e0188456.
    PubMed     Text format     Abstract available


  246. SENAPATI R, Nayak B, Kar SK, Dwibedi B, et al
    HPV genotypes co-infections associated with cervical carcinoma: Special focus on phylogenetically related and non-vaccine targeted genotypes.
    PLoS One. 2017;12:e0187844.
    PubMed     Text format     Abstract available


  247. VAN DER HEIJDEN EMDL, Chileshe J, Vernooij JCM, Gortazar C, et al
    Immune response profiles of calves following vaccination with live BCG and inactivated Mycobacterium bovis vaccine candidates.
    PLoS One. 2017;12:e0188448.
    PubMed     Text format     Abstract available


  248. RALEIGH MD, Peterson SJ, Laudenbach M, Baruffaldi F, et al
    Safety and efficacy of an oxycodone vaccine: Addressing some of the unique considerations posed by opioid abuse.
    PLoS One. 2017;12:e0184876.
    PubMed     Text format     Abstract available


  249. BOMMANA S, Walker E, Desclozeaux M, Timms P, et al
    Humoral immune response against two surface antigens of Chlamydia pecorum in vaccinated and naturally infected sheep.
    PLoS One. 2017;12:e0188370.
    PubMed     Text format     Abstract available


  250. ORTIZ AP, Ortiz-Ortiz KJ, Rios M, Laborde J, et al
    Modelling the effects of quadrivalent Human Papillomavirus (HPV) vaccination in Puerto Rico.
    PLoS One. 2017;12:e0184540.
    PubMed     Text format     Abstract available


  251. KUZNIK A, Iliyasu G, Lamorde M, Mahmud M, et al
    Cost-effectiveness of expanding childhood routine immunization against Neisseria meningitidis serogroups C, W and Y with a quadrivalent conjugate vaccine in the African meningitis belt.
    PLoS One. 2017;12:e0188595.
    PubMed     Text format     Abstract available



  252. Correction: Direct and indirect impact of 10-valent pneumococcal conjugate vaccine introduction on pneumonia hospitalizations and economic burden in all age-groups in Brazil: A time-series analysis.
    PLoS One. 2017;12:e0189039.
    PubMed     Text format     Abstract available


  253. PRAPHASIRI P, Ditsungnoen D, Sirilak S, Rattanayot J, et al
    Predictors of seasonal influenza vaccination among older adults in Thailand.
    PLoS One. 2017;12:e0188422.
    PubMed     Text format     Abstract available


  254. CAYATTE C, Snell Bennett A, Rajani GM, Hostetler L, et al
    Inferior immunogenicity and efficacy of respiratory syncytial virus fusion protein-based subunit vaccine candidates in aged versus young mice.
    PLoS One. 2017;12:e0188708.
    PubMed     Text format     Abstract available


  255. CHAISRI U, Tungtrongchitr A, Indrawattana N, Meechan P, et al
    Immunotherapeutic efficacy of liposome-encapsulated refined allergen vaccines against Dermatophagoides pteronyssinus allergy.
    PLoS One. 2017;12:e0188627.
    PubMed     Text format     Abstract available


  256. XING J, Singh S, Zhao Y, Duan Y, et al
    Increasing vaccine production using pulsed ultrasound waves.
    PLoS One. 2017;12:e0187048.
    PubMed     Text format     Abstract available


  257. MEUNIER M, Guyard-Nicodeme M, Vigouroux E, Poezevara T, et al
    Promising new vaccine candidates against Campylobacter in broilers.
    PLoS One. 2017;12:e0188472.
    PubMed     Text format     Abstract available


  258. MURRAY J, Todd KV, Bakre A, Orr-Burks N, et al
    A universal mammalian vaccine cell line substrate.
    PLoS One. 2017;12:e0188333.
    PubMed     Text format     Abstract available


  259. BRUXELLE JF, Mizrahi A, Hoys S, Collignon A, et al
    Clostridium difficile flagellin FliC: Evaluation as adjuvant and use in a mucosal vaccine against Clostridium difficile.
    PLoS One. 2017;12:e0187212.
    PubMed     Text format     Abstract available


  260. JEE PF, Tiong V, Shu MH, Khoo JJ, et al
    Oral immunization of a non-recombinant Lactococcus lactis surface displaying influenza hemagglutinin 1 (HA1) induces mucosal immunity in mice.
    PLoS One. 2017;12:e0187718.
    PubMed     Text format     Abstract available


  261. LIM J, Kim K, Choi S, Park SM, et al
    The effectiveness and limitation of the national childhood hepatitis A vaccination program in the Republic of Korea: Findings from the Korean National Health and Nutrition Examination Survey (KNHANES), 2015.
    PLoS One. 2017;12:e0189210.
    PubMed     Text format     Abstract available


  262. DORTA-ESTREMERA S, Nehete PN, Yang G, He H, et al
    Minimally invasive monitoring of CD4 T cells at multiple mucosal tissues after intranasal vaccination in rhesus macaques.
    PLoS One. 2017;12:e0188807.
    PubMed     Text format     Abstract available


  263. KIM YG, Baltabekova AZ, Zhiyenbay EE, Aksambayeva AS, et al
    Recombinant Vaccinia virus-coded interferon inhibitor B18R: Expression, refolding and a use in a mammalian expression system with a RNA-vector.
    PLoS One. 2017;12:e0189308.
    PubMed     Text format     Abstract available


    January 2016
  264. WIJMENGA-MONSUUR AJ, van Westen E, Knol MJ, Jongerius RM, et al
    Correction: Direct Comparison of Immunogenicity Induced by 10- or 13-Valent Pneumococcal Conjugate Vaccine around the 11-Month Booster in Dutch Infants.
    PLoS One. 2016;11:e0155088.
    PubMed     Text format     Abstract available


  265. COSGROVE CA, Lacey CJ, Cope AV, Bartolf A, et al
    Comparative Immunogenicity of HIV-1 gp140 Vaccine Delivered by Parenteral, and Mucosal Routes in Female Volunteers; MUCOVAC2, A Randomized Two Centre Study.
    PLoS One. 2016;11:e0152038.
    PubMed     Text format     Abstract available


  266. ZHA J, Chi XW, Yu XL, Liu XM, et al
    Interleukin-1beta-Targeted Vaccine Improves Glucose Control and beta-Cell Function in a Diabetic KK-Ay Mouse Model.
    PLoS One. 2016;11:e0154298.
    PubMed     Text format     Abstract available


  267. MVULA H, Heinsbroek E, Chihana M, Crampin AC, et al
    Predictors of Uptake and Timeliness of Newly Introduced Pneumococcal and Rotavirus Vaccines, and of Measles Vaccine in Rural Malawi: A Population Cohort Study.
    PLoS One. 2016;11:e0154997.
    PubMed     Text format     Abstract available


  268. MARTIN SD, Brown SD, Wick DA, Nielsen JS, et al
    Low Mutation Burden in Ovarian Cancer May Limit the Utility of Neoantigen-Targeted Vaccines.
    PLoS One. 2016;11:e0155189.
    PubMed     Text format     Abstract available


  269. DEERE JD, Chang WL, Castillo LD, Schmidt KA, et al
    Utilizing a TLR5-Adjuvanted Cytomegalovirus as a Lentiviral Vaccine in the Nonhuman Primate Model for AIDS.
    PLoS One. 2016;11:e0155629.
    PubMed     Text format     Abstract available


  270. YU Z, Liu J, Wang X, Zhu X, et al
    Efficient Vaccine Distribution Based on a Hybrid Compartmental Model.
    PLoS One. 2016;11:e0155416.
    PubMed     Text format     Abstract available


  271. LU J, Wu P, Zhang X, Feng L, et al
    Immunopotentiators Improve the Efficacy of Oil-Emulsion-Inactivated Avian Influenza Vaccine in Chickens, Ducks and Geese.
    PLoS One. 2016;11:e0156573.
    PubMed     Text format     Abstract available


  272. ALLEN ER, van Diemen P, Yamaguchi Y, Lindemann C, et al
    MRI Based Localisation and Quantification of Abscesses following Experimental S. aureus Intravenous Challenge: Application to Vaccine Evaluation.
    PLoS One. 2016;11:e0154705.
    PubMed     Text format     Abstract available


  273. STONE J, Martin NK, Hickman M, Hellard M, et al
    The Potential Impact of a Hepatitis C Vaccine for People Who Inject Drugs: Is a Vaccine Needed in the Age of Direct-Acting Antivirals?
    PLoS One. 2016;11:e0156213.
    PubMed     Text format     Abstract available


  274. RAMANATHAN B, Poh CL, Kirk K, McBride WJ, et al
    Synthetic B-Cell Epitopes Eliciting Cross-Neutralizing Antibodies: Strategies for Future Dengue Vaccine.
    PLoS One. 2016;11:e0155900.
    PubMed     Text format     Abstract available


  275. KHAN SA, Desclozeaux M, Waugh C, Hanger J, et al
    Antibody and Cytokine Responses of Koalas (Phascolarctos cinereus) Vaccinated with Recombinant Chlamydial Major Outer Membrane Protein (MOMP) with Two Different Adjuvants.
    PLoS One. 2016;11:e0156094.
    PubMed     Text format     Abstract available


  276. LAUGHIN RC, Drake KL, Morrill JC, Adams LG, et al
    Correction: Correlative Gene Expression to Protective Seroconversion In Rift Valley Vaccinates.
    PLoS One. 2016;11:e0156469.
    PubMed     Text format     Abstract available


  277. NAVALPAKAM A, Dany M, Hajj Hussein I
    Behavioral Perceptions of Oakland University Female College Students towards Human Papillomavirus Vaccination.
    PLoS One. 2016;11:e0155955.
    PubMed     Text format     Abstract available


  278. VISSER O, Hautvast JL, van der Velden K, Hulscher ME, et al
    Intention to Accept Pertussis Vaccination for Cocooning: A Qualitative Study of the Determinants.
    PLoS One. 2016;11:e0155861.
    PubMed     Text format     Abstract available


  279. ADAMS J, McNaughton RJ, Wigham S, Flynn D, et al
    Acceptability of Parental Financial Incentives and Quasi-Mandatory Interventions for Preschool Vaccinations: Triangulation of Findings from Three Linked Studies.
    PLoS One. 2016;11:e0156843.
    PubMed     Text format     Abstract available


  280. KLUSHKINA VV, Kyuregyan KK, Kozhanova TV, Popova OE, et al
    Impact of Universal Hepatitis B Vaccination on Prevalence, Infection-Associated Morbidity and Mortality, and Circulation of Immune Escape Variants in Russia.
    PLoS One. 2016;11:e0157161.
    PubMed     Text format     Abstract available


  281. FULLEN DJ, Noulin N, Catchpole A, Fathi H, et al
    Correction: Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model.
    PLoS One. 2016;11:e0157211.
    PubMed     Text format     Abstract available


  282. DOWALL SD, Graham VA, Rayner E, Hunter L, et al
    Protective effects of a Modified Vaccinia Ankara-based vaccine candidate against Crimean-Congo Haemorrhagic Fever virus require both cellular and humoral responses.
    PLoS One. 2016;11:e0156637.
    PubMed     Text format     Abstract available


  283. LOMBARDI F, Belmonti S, Fabbiani M, Morandi M, et al
    Immunogenicity and Safety of the 13-Valent Pneumococcal Conjugate Vaccine versus the 23-Valent Polysaccharide Vaccine in Unvaccinated HIV-Infected Adults: A Pilot, Prospective Controlled Study.
    PLoS One. 2016;11:e0156523.
    PubMed     Text format     Abstract available


  284. JANG H, Ngunjiri JM, Lee CW
    Association between Interferon Response and Protective Efficacy of NS1-Truncated Mutants as Influenza Vaccine Candidates in Chickens.
    PLoS One. 2016;11:e0156603.
    PubMed     Text format     Abstract available


  285. MICHEL G, Ferrua B, Munro P, Boyer L, et al
    Immunoadjuvant Properties of the Rho Activating Factor CNF1 in Prophylactic and Curative Vaccination against Leishmania infantum.
    PLoS One. 2016;11:e0156363.
    PubMed     Text format     Abstract available


  286. DUBE E, Gagnon D, Ouakki M, Bettinger JA, et al
    Understanding Vaccine Hesitancy in Canada: Results of a Consultation Study by the Canadian Immunization Research Network.
    PLoS One. 2016;11:e0156118.
    PubMed     Text format     Abstract available


  287. MCNEILLY C, Cosh S, Vu T, Nichols J, et al
    Predicted Coverage and Immuno-Safety of a Recombinant C-Repeat Region Based Streptococcus pyogenes Vaccine Candidate.
    PLoS One. 2016;11:e0156639.
    PubMed     Text format     Abstract available


  288. KILANY WH, Safwat M, Mohammed SM, Salim A, et al
    Protective Efficacy of Recombinant Turkey Herpes Virus (rHVT-H5) and Inactivated H5N1 Vaccines in Commercial Mulard Ducks against the Highly Pathogenic Avian Influenza (HPAI) H5N1 Clade 2.2.1 Virus.
    PLoS One. 2016;11:e0156747.
    PubMed     Text format     Abstract available


  289. HEYDARCHI B, Center RJ, Gonelli C, Muller B, et al
    Repeated Vaccination of Cows with HIV Env gp140 during Subsequent Pregnancies Elicits and Sustains an Enduring Strong Env-Binding and Neutralising Antibody Response.
    PLoS One. 2016;11:e0157353.
    PubMed     Text format     Abstract available


  290. GULLBERG M, Lohse L, Botner A, McInerney GM, et al
    A Prime-Boost Vaccination Strategy in Cattle to Prevent Foot-and-Mouth Disease Using a "Single-Cycle" Alphavirus Vector and Empty Capsid Particles.
    PLoS One. 2016;11:e0157435.
    PubMed     Text format     Abstract available


  291. SPENSIERI F, Siena E, Borgogni E, Zedda L, et al
    Early Rise of Blood T Follicular Helper Cell Subsets and Baseline Immunity as Predictors of Persisting Late Functional Antibody Responses to Vaccination in Humans.
    PLoS One. 2016;11:e0157066.
    PubMed     Text format     Abstract available


  292. CHANG YC, Tung HJ, Hsu SW, Chen LS, et al
    Use of Seasonal Influenza Vaccination and Its Associated Factors among Elderly People with Disabilities in Taiwan: A Population-Based Study.
    PLoS One. 2016;11:e0158075.
    PubMed     Text format     Abstract available


  293. YOON S, Kim ED, Song MS, Han SJ, et al
    Eyedrop Vaccination Induced Systemic and Mucosal Immunity against Influenza Virus in Ferrets.
    PLoS One. 2016;11:e0157634.
    PubMed     Text format     Abstract available


  294. HARVEY MJ, Prosser LA, Messonnier ML, Hutton DW, et al
    Hitting the Optimal Vaccination Percentage and the Risks of Error: Why to Miss Right.
    PLoS One. 2016;11:e0156737.
    PubMed     Text format     Abstract available


  295. FENG XM, Zheng WY, Zhang HM, Shi WY, et al
    Vaccination with Bivalent DNA Vaccine of alpha1-Giardin and CWP2 Delivered by Attenuated Salmonella typhimurium Reduces Trophozoites and Cysts in the Feces of Mice Infected with Giardia lamblia.
    PLoS One. 2016;11:e0157872.
    PubMed     Text format     Abstract available


  296. GREENBERG RN, Hay CM, Stapleton JT, Marbury TC, et al
    A Randomized, Double-Blind, Placebo-Controlled Phase II Trial Investigating the Safety and Immunogenicity of Modified Vaccinia Ankara Smallpox Vaccine (MVA-BN(R)) in 56-80-Year-Old Subjects.
    PLoS One. 2016;11:e0157335.
    PubMed     Text format     Abstract available


  297. AKIN L, Macabeo B, Caliskan Z, Altinel S, et al
    Cost-Effectiveness of Increasing Influenza Vaccination Coverage in Adults with Type 2 Diabetes in Turkey.
    PLoS One. 2016;11:e0157657.
    PubMed     Text format     Abstract available


  298. HART PJ, O'Shaughnessy CM, Siggins MK, Bobat S, et al
    Differential Killing of Salmonella enterica Serovar Typhi by Antibodies Targeting Vi and Lipopolysaccharide O:9 Antigen.
    PLoS One. 2016;11:e0145945.
    PubMed     Text format     Abstract available


  299. RABINOWITZ M, Latella L, Stern C, Jost JT, et al
    Beliefs about Childhood Vaccination in the United States: Political Ideology, False Consensus, and the Illusion of Uniqueness.
    PLoS One. 2016;11:e0158382.
    PubMed     Text format     Abstract available


  300. THOMAS MA, Nyanhete T, Tuero I, Venzon D, et al
    Beyond Oncolytics: E1B55K-Deleted Adenovirus as a Vaccine Delivery Vector.
    PLoS One. 2016;11:e0158505.
    PubMed     Text format     Abstract available


  301. GILKEY MB, McRee AL, Magnus BE, Reiter PL, et al
    Vaccination Confidence and Parental Refusal/Delay of Early Childhood Vaccines.
    PLoS One. 2016;11:e0159087.
    PubMed     Text format     Abstract available


  302. MULLER L, Meyer M, Bauer RN, Zhou H, et al
    Effect of Broccoli Sprouts and Live Attenuated Influenza Virus on Peripheral Blood Natural Killer Cells: A Randomized, Double-Blind Study.
    PLoS One. 2016;11:e0147742.
    PubMed     Text format     Abstract available


  303. SCHIFFNER-ROHE J, Witt A, Hemmerling J, von Eiff C, et al
    Efficacy of PPV23 in Preventing Pneumococcal Pneumonia in Adults at Increased Risk--A Systematic Review and Meta-Analysis.
    PLoS One. 2016;11:e0146338.
    PubMed     Text format     Abstract available


  304. CARDENAS-GARCIA S, Dunwoody RP, Marcano V, Diel DG, et al
    Effects of Chicken Interferon Gamma on Newcastle Disease Virus Vaccine Immunogenicity.
    PLoS One. 2016;11:e0159153.
    PubMed     Text format     Abstract available


  305. HERMES R, Schwarzenberger F, Goritz F, Oh S, et al
    Ovarian down Regulation by GnRF Vaccination Decreases Reproductive Tract Tumour Size in Female White and Greater One-Horned Rhinoceroses.
    PLoS One. 2016;11:e0157963.
    PubMed     Text format     Abstract available


  306. BLANCO-HEREDIA J, Lecanda A, Valenzuela-Ponce H, Brander C, et al
    Identification of Immunogenic Cytotoxic T Lymphocyte Epitopes Containing Drug Resistance Mutations in Antiretroviral Treatment-Naive HIV-Infected Individuals.
    PLoS One. 2016;11:e0147571.
    PubMed     Text format     Abstract available


  307. CAO Y, Bansal GP, Merino K, Kumar N, et al
    Immunological Cross-Reactivity between Malaria Vaccine Target Antigen P48/45 in Plasmodium vivax and P. falciparum and Cross-Boosting of Immune Responses.
    PLoS One. 2016;11:e0158212.
    PubMed     Text format     Abstract available


  308. SPEAKE C, Pichugin A, Sahu T, Malkov V, et al
    Identification of Novel Pre-Erythrocytic Malaria Antigen Candidates for Combination Vaccines with Circumsporozoite Protein.
    PLoS One. 2016;11:e0159449.
    PubMed     Text format     Abstract available


  309. TRAVASSOS MA, Beyene B, Adam Z, Campbell JD, et al
    Immunization Coverage Surveys and Linked Biomarker Serosurveys in Three Regions in Ethiopia.
    PLoS One. 2016;11:e0149970.
    PubMed     Text format     Abstract available


  310. NGABO F, Mvundura M, Gazley L, Gatera M, et al
    The Economic Burden Attributable to a Child's Inpatient Admission for Diarrheal Disease in Rwanda.
    PLoS One. 2016;11:e0149805.
    PubMed     Text format     Abstract available


  311. BOLLAERTS K, Shinde V, Dos Santos G, Ferreira G, et al
    Application of Probabilistic Multiple-Bias Analyses to a Cohort- and a Case-Control Study on the Association between Pandemrix and Narcolepsy.
    PLoS One. 2016;11:e0149289.
    PubMed     Text format     Abstract available


  312. MANIGART O, Trotter C, Findlow H, Assefa A, et al
    A Seroepidemiological Study of Serogroup A Meningococcal Infection in the African Meningitis Belt.
    PLoS One. 2016;11:e0147928.
    PubMed     Text format     Abstract available


  313. GOGOI-TIWARI J, Williams V, Waryah CB, Mathavan S, et al
    Intramammary Immunization of Pregnant Mice with Staphylococcal Protein A Reduces the Post-Challenge Mammary Gland Bacterial Load but Not Pathology.
    PLoS One. 2016;11:e0148383.
    PubMed     Text format     Abstract available


  314. CASARIN E, Lucchese L, Grazioli S, Facchin S, et al
    A New ELISA Using the ANANAS Technology Showing High Sensitivity to diagnose the Bovine Rhinotracheitis from Individual Sera to Pooled Milk.
    PLoS One. 2016;11:e0145912.
    PubMed     Text format     Abstract available


  315. PEDERSEN SR, Christensen JP, Buus S, Rasmussen M, et al
    Immunogenicity of HLA Class I and II Double Restricted Influenza A-Derived Peptides.
    PLoS One. 2016;11:e0145629.
    PubMed     Text format     Abstract available


  316. SUBHARAT S, Shu D, Zheng T, Buddle BM, et al
    Vaccination of Sheep with a Methanogen Protein Provides Insight into Levels of Antibody in Saliva Needed to Target Ruminal Methanogens.
    PLoS One. 2016;11:e0159861.
    PubMed     Text format     Abstract available


  317. LI M, Taylor EG, Atkins KE, Chapman GB, et al
    Stimulating Influenza Vaccination via Prosocial Motives.
    PLoS One. 2016;11:e0159780.
    PubMed     Text format     Abstract available


  318. SUZUKI Y, Odagiri T, Tashiro M, Nobusawa E, et al
    Development of an Influenza A Master Virus for Generating High-Growth Reassortants for A/Anhui/1/2013(H7N9) Vaccine Production in Qualified MDCK Cells.
    PLoS One. 2016;11:e0160040.
    PubMed     Text format     Abstract available


  319. ZAMBONELLI C, Dey AK, Hilt S, Stephenson S, et al
    Generation and Characterization of a Bivalent HIV-1 Subtype C gp120 Protein Boost for Proof-of-Concept HIV Vaccine Efficacy Trials in Southern Africa.
    PLoS One. 2016;11:e0157391.
    PubMed     Text format     Abstract available


  320. REINTJES R, Das E, Klemm C, Richardus JH, et al
    "Pandemic Public Health Paradox": Time Series Analysis of the 2009/10 Influenza A / H1N1 Epidemiology, Media Attention, Risk Perception and Public Reactions in 5 European Countries.
    PLoS One. 2016;11:e0151258.
    PubMed     Text format     Abstract available


  321. TEN HAVE R, Reubsaet K, van Herpen P, Kersten G, et al
    Demonstrating Functional Equivalence of Pilot and Production Scale Freeze-Drying of BCG.
    PLoS One. 2016;11:e0151239.
    PubMed     Text format     Abstract available


  322. GONZALEZ-PENA D, Nixon SE, O'Connor JC, Southey BR, et al
    Microglia Transcriptome Changes in a Model of Depressive Behavior after Immune Challenge.
    PLoS One. 2016;11:e0150858.
    PubMed     Text format     Abstract available


  323. MUNANG'ANDU HM, Santi N, Fredriksen BN, Lokling KE, et al
    A Systematic Approach towards Optimizing a Cohabitation Challenge Model for Infectious Pancreatic Necrosis Virus in Atlantic Salmon (Salmo salar L.).
    PLoS One. 2016;11:e0148467.
    PubMed     Text format     Abstract available


  324. DANIELS-TREFFANDIER H, de Nie K, Marsay L, Dold C, et al
    Impact of Reducing Complement Inhibitor Binding on the Immunogenicity of Native Neisseria meningitidis Outer Membrane Vesicles.
    PLoS One. 2016;11:e0148840.
    PubMed     Text format     Abstract available


  325. LOMBARD R, Doz E, Carreras F, Epardaud M, et al
    IL-17RA in Non-Hematopoietic Cells Controls CXCL-1 and 5 Critical to Recruit Neutrophils to the Lung of Mycobacteria-Infected Mice during the Adaptive Immune Response.
    PLoS One. 2016;11:e0149455.
    PubMed     Text format     Abstract available


  326. MARIMON JM, Ercibengoa M, Tamayo E, Alonso M, et al
    Long-Term Epidemiology of Streptococcus pneumoniae Serogroup 6 in a Region of Southern Europe with Special Reference to Serotype 6E.
    PLoS One. 2016;11:e0149047.
    PubMed     Text format     Abstract available


  327. ALVARADO-FACUNDO E, Vassell R, Schmeisser F, Weir JP, et al
    Glycosylation of Residue 141 of Subtype H7 Influenza A Hemagglutinin (HA) Affects HA-Pseudovirus Infectivity and Sensitivity to Site A Neutralizing Antibodies.
    PLoS One. 2016;11:e0149149.
    PubMed     Text format     Abstract available


  328. MUTURI-KIOI V, Lewis D, Launay O, Leroux-Roels G, et al
    Neutropenia as an Adverse Event following Vaccination: Results from Randomized Clinical Trials in Healthy Adults and Systematic Review.
    PLoS One. 2016;11:e0157385.
    PubMed     Text format     Abstract available


  329. FELL DB, Wilson K, Ducharme R, Hawken S, et al
    Infant Respiratory Outcomes Associated with Prenatal Exposure to Maternal 2009 A/H1N1 Influenza Vaccination.
    PLoS One. 2016;11:e0160342.
    PubMed     Text format     Abstract available


  330. KUMAKECH E, Berggren V, Wabinga H, Lillsunde-Larsson G, et al
    Significantly Reduced Genoprevalence of Vaccine-Type HPV-16/18 Infections among Vaccinated Compared to Non-Vaccinated Young Women 5.5 Years after a Bivalent HPV-16/18 Vaccine (Cervarix(R)) Pilot Project in Uganda.
    PLoS One. 2016;11:e0160099.
    PubMed     Text format     Abstract available


  331. ROTH A, Glaesener S, Schutz K, Meyer-Bahlburg A, et al
    Reduced Number of Transitional and Naive B Cells in Addition to Decreased BAFF Levels in Response to the T Cell Independent Immunogen Pneumovax(R)23.
    PLoS One. 2016;11:e0152215.
    PubMed     Text format     Abstract available


  332. GUPTA M, Angeli F, Bosma H, Rana M, et al
    Effectiveness of Multiple-Strategy Community Intervention in Reducing Geographical, Socioeconomic and Gender Based Inequalities in Maternal and Child Health Outcomes in Haryana, India.
    PLoS One. 2016;11:e0150537.
    PubMed     Text format     Abstract available


  333. VEGUILLA V, Lopez-Gatell H, Lopez-Martinez I, Aparicio-Antonio R, et al
    A Large Proportion of the Mexican Population Remained Susceptible to A(H1N1)pdm09 Infection One Year after the Emergence of 2009 Influenza Pandemic.
    PLoS One. 2016;11:e0150428.
    PubMed     Text format     Abstract available


  334. KAWAHARA M, Hasegawa N, Takaku H
    Murine Splenic Natural Killer Cells Do Not Develop Immunological Memory after Re-Encounter with Mycobacterium bovis BCG.
    PLoS One. 2016;11:e0152051.
    PubMed     Text format     Abstract available


  335. MELO R, Richer L, Johnson DL, Gomes-Solecki M, et al
    Oral Immunization with OspC Does Not Prevent Tick-Borne Borrelia burgdorferi Infection.
    PLoS One. 2016;11:e0151850.
    PubMed     Text format     Abstract available


  336. MESHER D, Stanford E, White J, Findlow J, et al
    HPV Serology Testing Confirms High HPV Immunisation Coverage in England.
    PLoS One. 2016;11:e0150107.
    PubMed     Text format     Abstract available


  337. NORRIS A, Hachey K, Curtis A, Bourdeaux M, et al
    Crippling Violence: Conflict and Incident Polio in Afghanistan.
    PLoS One. 2016;11:e0149074.
    PubMed     Text format     Abstract available


  338. NGO CC, Massa HM, Thornton RB, Cripps AW, et al
    Predominant Bacteria Detected from the Middle Ear Fluid of Children Experiencing Otitis Media: A Systematic Review.
    PLoS One. 2016;11:e0150949.
    PubMed     Text format     Abstract available


  339. DEL AMO E, Esteva C, Hernandez-Bou S, Galles C, et al
    Serotypes and Clonal Diversity of Streptococcus pneumoniae Causing Invasive Disease in the Era of PCV13 in Catalonia, Spain.
    PLoS One. 2016;11:e0151125.
    PubMed     Text format     Abstract available


  340. POSUWAN N, Wanlapakorn N, Sa-Nguanmoo P, Wasitthankasem R, et al
    The Success of a Universal Hepatitis B Immunization Program as Part of Thailand's EPI after 22 Years' Implementation.
    PLoS One. 2016;11:e0150499.
    PubMed     Text format     Abstract available


  341. SZCZEPANEK SM, Roberts S, Rogers K, Cotte C, et al
    Poor Long-Term Efficacy of Prevnar-13 in Sickle Cell Disease Mice Is Associated with an Inability to Sustain Pneumococcal-Specific Antibody Titers.
    PLoS One. 2016;11:e0149261.
    PubMed     Text format     Abstract available


  342. XIONG W, Dong H, Wang J, Zou X, et al
    Analysis of Plasma Cytokine and Chemokine Profiles in Patients with and without Tuberculosis by Liquid Array-Based Multiplexed Immunoassays.
    PLoS One. 2016;11:e0148885.
    PubMed     Text format     Abstract available


  343. MCKINNEY BA, Lareau C, Oberg AL, Kennedy RB, et al
    The Integration of Epistasis Network and Functional Interactions in a GWAS Implicates RXR Pathway Genes in the Immune Response to Smallpox Vaccine.
    PLoS One. 2016;11:e0158016.
    PubMed     Text format     Abstract available


  344. PRAYGOD G, Mukerebe C, Magawa R, Jeremiah K, et al
    Indoor Air Pollution and Delayed Measles Vaccination Increase the Risk of Severe Pneumonia in Children: Results from a Case-Control Study in Mwanza, Tanzania.
    PLoS One. 2016;11:e0160804.
    PubMed     Text format     Abstract available


  345. HUMBERT MV, Hung MC, Phillips R, Akoto C, et al
    Vaccine Potential and Diversity of the Putative Cell Binding Factor (CBF, NMB0345/NEIS1825) Protein of Neisseria meningitidis.
    PLoS One. 2016;11:e0160403.
    PubMed     Text format     Abstract available


  346. MADAMPAGE CA, Wilson D, Townsend H, Crockford G, et al
    Cattle Immunized with a Recombinant Subunit Vaccine Formulation Exhibits a Trend towards Protection against Histophilus somni Bacterial Challenge.
    PLoS One. 2016;11:e0159070.
    PubMed     Text format     Abstract available


  347. GACH JS, Gorlani A, Dotsey EY, Becerra JC, et al
    HIV-1-Specific Antibody Response and Function after DNA Prime and Recombinant Adenovirus 5 Boost HIV Vaccine in HIV-Infected Subjects.
    PLoS One. 2016;11:e0160341.
    PubMed     Text format     Abstract available


  348. ANDERSON CS, DeDiego ML, Thakar J, Topham DJ, et al
    Novel Sequence-Based Mapping of Recently Emerging H5NX Influenza Viruses Reveals Pandemic Vaccine Candidates.
    PLoS One. 2016;11:e0160510.
    PubMed     Text format     Abstract available


  349. KESSANS SA, Linhart MD, Meador LR, Kilbourne J, et al
    Immunological Characterization of Plant-Based HIV-1 Gag/Dgp41 Virus-Like Particles.
    PLoS One. 2016;11:e0151842.
    PubMed     Text format     Abstract available


  350. PORTER CK, Riddle MS, Alcala AN, Sack DA, et al
    An Evidenced-Based Scale of Disease Severity following Human Challenge with Enteroxigenic Escherichia coli.
    PLoS One. 2016;11:e0149358.
    PubMed     Text format     Abstract available


  351. DEY A, Molodecky NA, Verma H, Sharma P, et al
    Human Circulating Antibody-Producing B Cell as a Predictive Measure of Mucosal Immunity to Poliovirus.
    PLoS One. 2016;11:e0146010.
    PubMed     Text format     Abstract available


  352. HARALAMBIEVA IH, Zimmermann MT, Ovsyannikova IG, Grill DE, et al
    Whole Transcriptome Profiling Identifies CD93 and Other Plasma Cell Survival Factor Genes Associated with Measles-Specific Antibody Response after Vaccination.
    PLoS One. 2016;11:e0160970.
    PubMed     Text format     Abstract available


  353. VAN DER LINDEN M, Falkenhorst G, Perniciaro S, Fitzner C, et al
    Effectiveness of Pneumococcal Conjugate Vaccines (PCV7 and PCV13) against Invasive Pneumococcal Disease among Children under Two Years of Age in Germany.
    PLoS One. 2016;11:e0161257.
    PubMed     Text format     Abstract available


  354. BILLESKOV R, Tan EV, Cang M, Abalos RM, et al
    Testing the H56 Vaccine Delivered in 4 Different Adjuvants as a BCG-Booster in a Non-Human Primate Model of Tuberculosis.
    PLoS One. 2016;11:e0161217.
    PubMed     Text format     Abstract available


  355. MAGINI D, Giovani C, Mangiavacchi S, Maccari S, et al
    Self-Amplifying mRNA Vaccines Expressing Multiple Conserved Influenza Antigens Confer Protection against Homologous and Heterosubtypic Viral Challenge.
    PLoS One. 2016;11:e0161193.
    PubMed     Text format     Abstract available


  356. MALO CS, Renner DN, Huseby Kelcher AM, Jin F, et al
    The Effect of Vector Silencing during Picornavirus Vaccination against Experimental Melanoma and Glioma.
    PLoS One. 2016;11:e0162064.
    PubMed     Text format     Abstract available


  357. PATYKOWSKI J, Dell M, Gibson M
    Germination Ecology and Seed Dispersal of a Critically Endangered Plant: A Case Study of Pomaderris vacciniifolia (Round-Leaf Pomaderris).
    PLoS One. 2016;11:e0161665.
    PubMed     Text format     Abstract available


  358. RESENDE LA, Aguiar-Soares RD, Gama-Ker H, Roatt BM, et al
    Impact of LbSapSal Vaccine in Canine Immunological and Parasitological Features before and after Leishmania chagasi-Challenge.
    PLoS One. 2016;11:e0161169.
    PubMed     Text format     Abstract available


  359. LEE DH, Lee SH, Kim AR, Quan FS, et al
    Virus-Like Nanoparticle Vaccine Confers Protection against Toxoplasma gondii.
    PLoS One. 2016;11:e0161231.
    PubMed     Text format     Abstract available


  360. HOONAKKER ME, Verhagen LM, Pupo E, de Haan A, et al
    Vaccine-Mediated Activation of Human TLR4 Is Affected by Modulation of Culture Conditions during Whole-Cell Pertussis Vaccine Preparation.
    PLoS One. 2016;11:e0161428.
    PubMed     Text format     Abstract available


  361. LATASA C, Echeverz M, Garcia B, Gil C, et al
    Evaluation of a Salmonella Strain Lacking the Secondary Messenger C-di-GMP and RpoS as a Live Oral Vaccine.
    PLoS One. 2016;11:e0161216.
    PubMed     Text format     Abstract available


  362. CEBEY-LOPEZ M, Herberg J, Pardo-Seco J, Gomez-Carballa A, et al
    Does Viral Co-Infection Influence the Severity of Acute Respiratory Infection in Children?
    PLoS One. 2016;11:e0152481.
    PubMed     Text format     Abstract available


  363. KLAUSBERGER M, Tscheliessnig R, Neff S, Nachbagauer R, et al
    Globular Head-Displayed Conserved Influenza H1 Hemagglutinin Stalk Epitopes Confer Protection against Heterologous H1N1 Virus.
    PLoS One. 2016;11:e0153579.
    PubMed     Text format     Abstract available


  364. ZURAWSKI G, Zurawski S, Flamar AL, Richert L, et al
    Targeting HIV-1 Env gp140 to LOX-1 Elicits Immune Responses in Rhesus Macaques.
    PLoS One. 2016;11:e0153484.
    PubMed     Text format     Abstract available


  365. QUAN V, Verani JR, Cohen C, von Gottberg A, et al
    Invasive Group B Streptococcal Disease in South Africa: Importance of Surveillance Methodology.
    PLoS One. 2016;11:e0152524.
    PubMed     Text format     Abstract available


  366. GUO Z, Xiao D, Li D, Wang X, et al
    Predicting and Evaluating the Epidemic Trend of Ebola Virus Disease in the 2014-2015 Outbreak and the Effects of Intervention Measures.
    PLoS One. 2016;11:e0152438.
    PubMed     Text format     Abstract available


  367. HAMMAMI P, Lancelot R, Lesnoff M
    Modelling the Dynamics of Post-Vaccination Immunity Rate in a Population of Sahelian Sheep after a Vaccination Campaign against Peste des Petits Ruminants Virus.
    PLoS One. 2016;11:e0161769.
    PubMed     Text format     Abstract available


  368. CHURCHYARD G, Mlisana K, Karuna S, Williamson AL, et al
    Sequential Immunization with gp140 Boosts Immune Responses Primed by Modified Vaccinia Ankara or DNA in HIV-Uninfected South African Participants.
    PLoS One. 2016;11:e0161753.
    PubMed     Text format     Abstract available


  369. ALI Z, Harastani H, Hammadi M, Reslan L, et al
    Rotavirus Genotypes and Vaccine Effectiveness from a Sentinel, Hospital-Based, Surveillance Study for Three Consecutive Rotavirus Seasons in Lebanon.
    PLoS One. 2016;11:e0161345.
    PubMed     Text format     Abstract available


  370. KATIVHU CL, Libraty DH
    A Model to Explain How the Bacille Calmette Guerin (BCG) Vaccine Drives Interleukin-12 Production in Neonates.
    PLoS One. 2016;11:e0162148.
    PubMed     Text format     Abstract available


  371. TUNG IL, Machalek DA, Garland SM
    Attitudes, Knowledge and Factors Associated with Human Papillomavirus (HPV) Vaccine Uptake in Adolescent Girls and Young Women in Victoria, Australia.
    PLoS One. 2016;11:e0161846.
    PubMed     Text format     Abstract available


  372. WANG Z, Chen Y, Xie S, Lv H, et al
    Changing Epidemiological Characteristics of Hepatitis A in Zhejiang Province, China: Increased Susceptibility in Adults.
    PLoS One. 2016;11:e0153804.
    PubMed     Text format     Abstract available


  373. URANGA S, Marinova D, Martin C, Pardo J, et al
    Granzyme A Is Expressed in Mouse Lungs during Mycobacterium tuberculosis Infection but Does Not Contribute to Protection In Vivo.
    PLoS One. 2016;11:e0153028.
    PubMed     Text format     Abstract available


  374. CHANTHAVILAY P, Reinharz D, Mayxay M, Phongsavan K, et al
    Economic Evaluation of Screening Strategies Combined with HPV Vaccination of Preadolescent Girls for the Prevention of Cervical Cancer in Vientiane, Lao PDR.
    PLoS One. 2016;11:e0162915.
    PubMed     Text format     Abstract available


  375. OLIVEIRA ER, Goncalves AJ, Costa SM, Azevedo AS, et al
    Aspects of T Cell-Mediated Immunity Induced in Mice by a DNA Vaccine Based on the Dengue-NS1 Antigen after Challenge by the Intracerebral Route.
    PLoS One. 2016;11:e0163240.
    PubMed     Text format     Abstract available


  376. NOH JY, Park JK, Lee DH, Yuk SS, et al
    Chimeric Bivalent Virus-Like Particle Vaccine for H5N1 HPAI and ND Confers Protection against a Lethal Challenge in Chickens and Allows a Strategy of Differentiating Infected from Vaccinated Animals (DIVA).
    PLoS One. 2016;11:e0162946.
    PubMed     Text format     Abstract available


  377. AYALA AJ, Dimitrov KM, Becker CR, Goraichuk IV, et al
    Presence of Vaccine-Derived Newcastle Disease Viruses in Wild Birds.
    PLoS One. 2016;11:e0162484.
    PubMed     Text format     Abstract available


  378. JUON HS, Strong C, Kim F, Park E, et al
    Lay Health Worker Intervention Improved Compliance with Hepatitis B Vaccination in Asian Americans: Randomized Controlled Trial.
    PLoS One. 2016;11:e0162683.
    PubMed     Text format     Abstract available


  379. MOLBAK K, Hansen ND, Valentiner-Branth P
    Pre-Vaccination Care-Seeking in Females Reporting Severe Adverse Reactions to HPV Vaccine. A Registry Based Case-Control Study.
    PLoS One. 2016;11:e0162520.
    PubMed     Text format     Abstract available


  380. MAMEDOV T, Chichester JA, Jones RM, Ghosh A, et al
    Production of Functionally Active and Immunogenic Non-Glycosylated Protective Antigen from Bacillus anthracis in Nicotiana benthamiana by Co-Expression with Peptide-N-Glycosidase F (PNGase F) of Flavobacterium meningosepticum.
    PLoS One. 2016;11:e0153956.
    PubMed     Text format     Abstract available


  381. NI G, Chen S, Yang Y, Cummins SF, et al
    Investigation the Possibility of Using Peptides with a Helical Repeating Pattern of Hydro-Phobic and Hydrophilic Residues to Inhibit IL-10.
    PLoS One. 2016;11:e0153939.
    PubMed     Text format     Abstract available


  382. TANMOY AM, Ahmed AN, Arumugam R, Hossain B, et al
    Rotavirus Surveillance at a WHO-Coordinated Invasive Bacterial Disease Surveillance Site in Bangladesh: A Feasibility Study to Integrate Two Surveillance Systems.
    PLoS One. 2016;11:e0153582.
    PubMed     Text format     Abstract available


  383. NJOM NLEND AE, Nguwoh PS, Ngounouh CT, Tchidjou HK, et al
    HIV-Infected or -Exposed Children Exhibit Lower Immunogenicity to Hepatitis B Vaccine in Yaounde, Cameroon: An Appeal for Revised Policies in Tropical Settings?
    PLoS One. 2016;11:e0161714.
    PubMed     Text format     Abstract available


  384. WONG LP, Raja Muhammad Yusoff RN, Edib Z, Sam IC, et al
    Nationwide Survey of Knowledge and Health Beliefs regarding Human Papillomavirus among HPV-Vaccinated Female Students in Malaysia.
    PLoS One. 2016;11:e0163156.
    PubMed     Text format     Abstract available


  385. KORAM KA, Adu B, Ocran J, Karikari YS, et al
    Safety and Immunogenicity of EBA-175 RII-NG Malaria Vaccine Administered Intramuscularly in Semi-Immune Adults: A Phase 1, Double-Blinded Placebo Controlled Dosage Escalation Study.
    PLoS One. 2016;11:e0163066.
    PubMed     Text format     Abstract available


  386. SALK HM, Simon WL, Lambert ND, Kennedy RB, et al
    Taxa of the Nasal Microbiome Are Associated with Influenza-Specific IgA Response to Live Attenuated Influenza Vaccine.
    PLoS One. 2016;11:e0162803.
    PubMed     Text format     Abstract available


  387. POUWELS KB, Bozdemir SE, Yegenoglu S, Celebi S, et al
    Potential Cost-Effectiveness of RSV Vaccination of Infants and Pregnant Women in Turkey: An Illustration Based on Bursa Data.
    PLoS One. 2016;11:e0163567.
    PubMed     Text format     Abstract available


  388. SPRUIJT IT, de Lange MM, Dijkstra F, Donker GA, et al
    Long-Term Correlation between Influenza Vaccination Coverage and Incidence of Influenza-Like Illness in 14 European Countries.
    PLoS One. 2016;11:e0163508.
    PubMed     Text format     Abstract available


  389. DHARMASENA MN, Feuille CM, Starke CE, Bhagwat AA, et al
    Development of an Acid-Resistant Salmonella Typhi Ty21a Attenuated Vector For Improved Oral Vaccine Delivery.
    PLoS One. 2016;11:e0163511.
    PubMed     Text format     Abstract available


  390. THOMPSON M, Heath SL, Sweeton B, Williams K, et al
    DNA/MVA Vaccination of HIV-1 Infected Participants with Viral Suppression on Antiretroviral Therapy, followed by Treatment Interruption: Elicitation of Immune Responses without Control of Re-Emergent Virus.
    PLoS One. 2016;11:e0163164.
    PubMed     Text format     Abstract available


  391. ROUXEL RN, Merour E, Biacchesi S, Bremont M, et al
    Complete Protection against Influenza Virus H1N1 Strain A/PR/8/34 Challenge in Mice Immunized with Non-Adjuvanted Novirhabdovirus Vaccines.
    PLoS One. 2016;11:e0164245.
    PubMed     Text format     Abstract available


  392. CHOI HG, Choi S, Back YW, Park HS, et al
    Mycobacterium tuberculosis Rv2882c Protein Induces Activation of Macrophages through TLR4 and Exhibits Vaccine Potential.
    PLoS One. 2016;11:e0164458.
    PubMed     Text format     Abstract available


  393. HADJIPANAYIS A, Efstathiou E, Alexandrou M, Panayiotou L, et al
    Nasopharyngeal Pneumococcal Carriage among Healthy Children in Cyprus Post Widespread Simultaneous Implementation of PCV10 and PCV13 Vaccines.
    PLoS One. 2016;11:e0163269.
    PubMed     Text format     Abstract available


  394. SEDEGAH M, Peters B, Hollingdale MR, Ganeshan HD, et al
    Vaccine Strain-Specificity of Protective HLA-Restricted Class 1 P. falciparum Epitopes.
    PLoS One. 2016;11:e0163026.
    PubMed     Text format     Abstract available


  395. FABER BW, Hellwig S, Houard S, Havelange N, et al
    Production, Quality Control, Stability and Pharmacotoxicity of a Malaria Vaccine Comprising Three Highly Similar PfAMA1 Protein Molecules to Overcome Antigenic Variation.
    PLoS One. 2016;11:e0164053.
    PubMed     Text format     Abstract available


  396. HARRISON D, Wilding J, Bowman A, Fuller A, et al
    Using YouTube to Disseminate Effective Vaccination Pain Treatment for Babies.
    PLoS One. 2016;11:e0164123.
    PubMed     Text format     Abstract available


  397. SPEAKE C, Pichugin A, Sahu T, Malkov V, et al
    Correction: Identification of Novel Pre-Erythrocytic Malaria Antigen Candidates for Combination Vaccines with Circumsporozoite Protein.
    PLoS One. 2016;11:e0165489.
    PubMed     Text format     Abstract available


  398. FLYNN JA, Durr E, Swoyer R, Cejas PJ, et al
    Stability Characterization of a Vaccine Antigen Based on the Respiratory Syncytial Virus Fusion Glycoprotein.
    PLoS One. 2016;11:e0164789.
    PubMed     Text format     Abstract available


  399. XIE J, Codd C, Mo K, He Y, et al
    Differential Adverse Event Profiles Associated with BCG as a Preventive Tuberculosis Vaccine or Therapeutic Bladder Cancer Vaccine Identified by Comparative Ontology-Based VAERS and Literature Meta-Analysis.
    PLoS One. 2016;11:e0164792.
    PubMed     Text format     Abstract available


  400. TALAAT KR, Ellis RD, Hurd J, Hentrich A, et al
    Safety and Immunogenicity of Pfs25-EPA/Alhydrogel(R), a Transmission Blocking Vaccine against Plasmodium falciparum: An Open Label Study in Malaria Naive Adults.
    PLoS One. 2016;11:e0163144.
    PubMed     Text format     Abstract available


  401. COLLINSON-PAUTZ MR, Slawin KM, Levitt JM, Spencer DM, et al
    MyD88/CD40 Genetic Adjuvant Function in Cutaneous Atypical Antigen-Presenting Cells Contributes to DNA Vaccine Immunogenicity.
    PLoS One. 2016;11:e0164547.
    PubMed     Text format     Abstract available


  402. PATEL MC, Wang W, Pletneva LM, Rajagopala SV, et al
    Enterovirus D-68 Infection, Prophylaxis, and Vaccination in a Novel Permissive Animal Model, the Cotton Rat (Sigmodon hispidus).
    PLoS One. 2016;11:e0166336.
    PubMed     Text format     Abstract available


  403. LAZARUS R, Kelly S, Snape MD, Vandermeulen C, et al
    Antibody Persistence and Booster Responses to Split-Virion H5N1 Avian Influenza Vaccine in Young and Elderly Adults.
    PLoS One. 2016;11:e0165384.
    PubMed     Text format     Abstract available


  404. LEE D, Park SM
    Cost-Effectiveness Analysis of Hepatitis B Vaccination Strategies to Prevent Perinatal Transmission in North Korea: Selective Vaccination vs. Universal Vaccination.
    PLoS One. 2016;11:e0165879.
    PubMed     Text format     Abstract available


  405. GUPTA S, Chaudhary K, Dhanda SK, Kumar R, et al
    A Platform for Designing Genome-Based Personalized Immunotherapy or Vaccine against Cancer.
    PLoS One. 2016;11:e0166372.
    PubMed     Text format     Abstract available


  406. FABIANI M, Riccardo F, Di Napoli A, Gargiulo L, et al
    Differences in Influenza Vaccination Coverage between Adult Immigrants and Italian Citizens at Risk for Influenza-Related Complications: A Cross-Sectional Study.
    PLoS One. 2016;11:e0166517.
    PubMed     Text format     Abstract available


  407. KAMBIRE D, Soeters HM, Ouedraogo-Traore R, Medah I, et al
    Nationwide Trends in Bacterial Meningitis before the Introduction of 13-Valent Pneumococcal Conjugate Vaccine-Burkina Faso, 2011-2013.
    PLoS One. 2016;11:e0166384.
    PubMed     Text format     Abstract available


  408. MINCHOLE E, Figueredo AL, Omenaca M, Panadero C, et al
    Seasonal Influenza A H1N1pdm09 Virus and Severe Outcomes: A Reason for Broader Vaccination in Non-Elderly, At-Risk People.
    PLoS One. 2016;11:e0165711.
    PubMed     Text format     Abstract available


  409. LINDSTRAND A, Kalyango J, Alfven T, Darenberg J, et al
    Pneumococcal Carriage in Children under Five Years in Uganda-Will Present Pneumococcal Conjugate Vaccines Be Appropriate?
    PLoS One. 2016;11:e0166018.
    PubMed     Text format     Abstract available


  410. WANG Y, Vlasova A, Velasquez DE, Saif LJ, et al
    Skin Vaccination against Rotavirus Using Microneedles: Proof of Concept in Gnotobiotic Piglets.
    PLoS One. 2016;11:e0166038.
    PubMed     Text format     Abstract available


  411. COTE-GRAVEL J, Brouillette E, Obradovic N, Ster C, et al
    Characterization of a vraG Mutant in a Genetically Stable Staphylococcus aureus Small-Colony Variant and Preliminary Assessment for Use as a Live-Attenuated Vaccine against Intrammamary Infections.
    PLoS One. 2016;11:e0166621.
    PubMed     Text format     Abstract available


  412. AHONKHAI V, Martins SF, Portet A, Lumpkin M, et al
    Speeding Access to Vaccines and Medicines in Low- and Middle-Income Countries: A Case for Change and a Framework for Optimized Product Market Authorization.
    PLoS One. 2016;11:e0166515.
    PubMed     Text format     Abstract available


  413. FLOOD A, Estrada M, McAdams D, Ji Y, et al
    Development of a Freeze-Dried, Heat-Stable Influenza Subunit Vaccine Formulation.
    PLoS One. 2016;11:e0164692.
    PubMed     Text format     Abstract available


  414. BALDO V, Cocchio S, Gallo T, Furlan P, et al
    Pneumococcal Conjugated Vaccine Reduces the High Mortality for Community-Acquired Pneumonia in the Elderly: an Italian Regional Experience.
    PLoS One. 2016;11:e0166637.
    PubMed     Text format     Abstract available


  415. CARVALHO TF, Haddad JP, Paixao TA, Santos RL, et al
    Meta-Analysis and Advancement of Brucellosis Vaccinology.
    PLoS One. 2016;11:e0166582.
    PubMed     Text format     Abstract available


  416. CRANK MC, Wilson EM, Novik L, Enama ME, et al
    Safety and Immunogenicity of a rAd35-EnvA Prototype HIV-1 Vaccine in Combination with rAd5-EnvA in Healthy Adults (VRC 012).
    PLoS One. 2016;11:e0166393.
    PubMed     Text format     Abstract available


  417. ROMLEY J, Goutam P, Sood N
    National Survey Indicates that Individual Vaccination Decisions Respond Positively to Community Vaccination Rates.
    PLoS One. 2016;11:e0166858.
    PubMed     Text format     Abstract available


  418. NUNES AM, Ribeiro GS, Ferreira IE, Moura AR, et al
    Meningococcal Carriage among Adolescents after Mass Meningococcal C Conjugate Vaccination Campaigns in Salvador, Brazil.
    PLoS One. 2016;11:e0166475.
    PubMed     Text format     Abstract available


  419. RASHID S, Labani S, Das BC
    Knowledge, Awareness and Attitude on HPV, HPV Vaccine and Cervical Cancer among the College Students in India.
    PLoS One. 2016;11:e0166713.
    PubMed     Text format     Abstract available


  420. HILLS T, Jakeman PG, Carlisle RC, Klenerman P, et al
    A Rapid-Response Humoral Vaccine Platform Exploiting Pre-Existing Non-Cognate Populations of Anti-Vaccine or Anti-Viral CD4+ T Helper Cells to Confirm B Cell Activation.
    PLoS One. 2016;11:e0166383.
    PubMed     Text format     Abstract available


  421. VOINSON M, Billiard S, Alvergne A
    Correction: Beyond Rational Decision-Making: Modelling the Influence of Cognitive Biases on the Dynamics of Vaccination Coverage.
    PLoS One. 2016;11:e0167842.
    PubMed     Text format     Abstract available


  422. TRYFINOPOULOU K, Kesanopoulos K, Xirogianni A, Marmaras N, et al
    Meningococcal Carriage in Military Recruits and University Students during the Pre MenB Vaccination Era in Greece (2014-2015).
    PLoS One. 2016;11:e0167404.
    PubMed     Text format     Abstract available


  423. NUGENT G, Yockney IJ, Whitford EJ, Cross ML, et al
    Field Trial of an Aerially-Distributed Tuberculosis Vaccine in a Low-Density Wildlife Population of Brushtail Possums (Trichosurus vulpecula).
    PLoS One. 2016;11:e0167144.
    PubMed     Text format     Abstract available


  424. BENARD A, Sala C, Pluschke G
    Mycobacterium ulcerans Mouse Model Refinement for Pre-Clinical Profiling of Vaccine Candidates.
    PLoS One. 2016;11:e0167059.
    PubMed     Text format     Abstract available


  425. NJOKU OS, Manak MM, O'Connell RJ, Shutt AL, et al
    An Evaluation of Selected Populations for HIV-1 Vaccine Cohort Development in Nigeria.
    PLoS One. 2016;11:e0166711.
    PubMed     Text format     Abstract available


  426. ZHENG X, Zhang N, Zhang X, Hao L, et al
    Correction: Investigation of a Measles Outbreak in China to Identify Gaps in Vaccination Coverage, Routes of Transmission, and Interventions.
    PLoS One. 2016;11:e0168222.
    PubMed     Text format     Abstract available


  427. GUNNALA R, Ogbuanu IU, Adegoke OJ, Scobie HM, et al
    Routine Vaccination Coverage in Northern Nigeria: Results from 40 District-Level Cluster Surveys, 2014-2015.
    PLoS One. 2016;11:e0167835.
    PubMed     Text format     Abstract available


  428. SAMMER D, Krause K, Gube M, Wagner K, et al
    Hydrophobins in the Life Cycle of the Ectomycorrhizal Basidiomycete Tricholoma vaccinum.
    PLoS One. 2016;11:e0167773.
    PubMed     Text format     Abstract available


  429. MENSAH VA, Gueye A, Ndiaye M, Edwards NJ, et al
    Safety, Immunogenicity and Efficacy of Prime-Boost Vaccination with ChAd63 and MVA Encoding ME-TRAP against Plasmodium falciparum Infection in Adults in Senegal.
    PLoS One. 2016;11:e0167951.
    PubMed     Text format     Abstract available


  430. VIARD JP, Assuied A, Levy Y, Souberbielle JC, et al
    No Positive Association between Vitamin D Level and Immune Responses to Hepatitis B and Streptococcus pneumoniae Vaccination in HIV-Infected Adults.
    PLoS One. 2016;11:e0168640.
    PubMed     Text format     Abstract available


  431. WANG B, Russell ML, Moss L, Fonseca K, et al
    Effect of Influenza Vaccination of Children on Infection Rate in Hutterite Communities: Follow-Up Study of a Randomized Trial.
    PLoS One. 2016;11:e0167281.
    PubMed     Text format     Abstract available


  432. DALZON B, Lebas C, Jimenez G, Gutjahr A, et al
    Poly(Lactic Acid) Nanoparticles Targeting alpha5beta1 Integrin as Vaccine Delivery Vehicle, a Prospective Study.
    PLoS One. 2016;11:e0167663.
    PubMed     Text format     Abstract available


  433. YASUDA T, Ura T, Taniguchi M, Yoshida H, et al
    Intradermal Delivery of Antigens Enhances Specific IgG and Diminishes IgE Production: Potential Use for Vaccination and Allergy Immunotherapy.
    PLoS One. 2016;11:e0167952.
    PubMed     Text format     Abstract available


  434. DE OLIVEIRA LH, Camacho LA, Coutinho ES, Martinez-Silveira MS, et al
    Impact and Effectiveness of 10 and 13-Valent Pneumococcal Conjugate Vaccines on Hospitalization and Mortality in Children Aged Less than 5 Years in Latin American Countries: A Systematic Review.
    PLoS One. 2016;11:e0166736.
    PubMed     Text format     Abstract available


  435. WONG C, Jiang M, You JH
    Potential Cost-Effectiveness of an Influenza Vaccination Program Offering Microneedle Patch for Vaccine Delivery in Children.
    PLoS One. 2016;11:e0169030.
    PubMed     Text format     Abstract available


  436. LAMBKIN-WILLIAMS R, Gelder C, Broughton R, Mallett CP, et al
    An Intranasal Proteosome-Adjuvanted Trivalent Influenza Vaccine Is Safe, Immunogenic & Efficacious in the Human Viral Influenza Challenge Model. Serum IgG & Mucosal IgA Are Important Correlates of Protection against Illness Associated with Inf
    PLoS One. 2016;11:e0163089.
    PubMed     Text format     Abstract available


  437. TOTA JE, Jiang M, Ramanakumar AV, Walter SD, et al
    Epidemiologic Evaluation of Human Papillomavirus Type Competition and the Potential for Type Replacement Post-Vaccination.
    PLoS One. 2016;11:e0166329.
    PubMed     Text format     Abstract available



  438. Correction: A Prime-Boost Vaccination Strategy in Cattle to Prevent Foot-and-Mouth Disease Using a "Single-Cycle" Alphavirus Vector and Empty Capsid Particles.
    PLoS One. 2016;11:e0169025.
    PubMed     Text format     Abstract available


  439. MBUNDA T, Tarimo EA, Chalamilla G, Bakari M, et al
    The Influence of Community Members on Participation by Youth in an HIV Vaccine Trial in Tanzania.
    PLoS One. 2016;11:e0168660.
    PubMed     Text format     Abstract available


  440. SEDEGAH M, Peters B, Hollingdale MR, Ganeshan HD, et al
    Correction: Vaccine Strain-Specificity of Protective HLA-Restricted Class 1 P. falciparum Epitopes.
    PLoS One. 2016;11:e0168952.
    PubMed     Text format     Abstract available


  441. LAHEY T, Laddy D, Hill K, Schaeffer J, et al
    Immunogenicity and Protective Efficacy of the DAR-901 Booster Vaccine in a Murine Model of Tuberculosis.
    PLoS One. 2016;11:e0168521.
    PubMed     Text format     Abstract available


  442. ROSSI R, Assaad R, Rebeschini A, Hamadeh R, et al
    Vaccination Coverage Cluster Surveys in Middle Dreib - Akkar, Lebanon: Comparison of Vaccination Coverage in Children Aged 12-59 Months Pre- and Post-Vaccination Campaign.
    PLoS One. 2016;11:e0168145.
    PubMed     Text format     Abstract available


  443. DANGOR Z, Cutland CL, Izu A, Kwatra G, et al
    Temporal Changes in Invasive Group B Streptococcus Serotypes: Implications for Vaccine Development.
    PLoS One. 2016;11:e0169101.
    PubMed     Text format     Abstract available


  444. JONES C, Sadarangani M, Lewis S, Payne I, et al
    Characterisation of the Immunomodulatory Effects of Meningococcal Opa Proteins on Human Peripheral Blood Mononuclear Cells and CD4+ T Cells.
    PLoS One. 2016;11:e0154153.
    PubMed     Text format     Abstract available


  445. ZHAO L, Mahony D, Cavallaro AS, Zhang B, et al
    Immunogenicity of Outer Membrane Proteins VirB9-1 and VirB9-2, a Novel Nanovaccine against Anaplasma marginale.
    PLoS One. 2016;11:e0154295.
    PubMed     Text format     Abstract available


  446. MERAT SJ, Molenkamp R, Wagner K, Koekkoek SM, et al
    Hepatitis C virus Broadly Neutralizing Monoclonal Antibodies Isolated 25 Years after Spontaneous Clearance.
    PLoS One. 2016;11:e0165047.
    PubMed     Text format     Abstract available


  447. RESTIVO V, Costantino C, Mammina C, Vitale F, et al
    Influenza like Illness among Medical Residents Anticipates Influenza Diffusion in General Population: Data from a National Survey among Italian Medical Residents.
    PLoS One. 2016;11:e0168546.
    PubMed     Text format     Abstract available


  448. NYIRENDA M, Omori R, Tessmer HL, Arimura H, et al
    Estimating the Lineage Dynamics of Human Influenza B Viruses.
    PLoS One. 2016;11:e0166107.
    PubMed     Text format     Abstract available


  449. VELJKOVIC V, Veljkovic N, Paessler S, Goeijenbier M, et al
    Predicted Enhanced Human Propensity of Current Avian-Like H1N1 Swine Influenza Virus from China.
    PLoS One. 2016;11:e0165451.
    PubMed     Text format     Abstract available


  450. TALEBI M, Azadegan A, Sadeghi J, Ahmadi A, et al
    Determination of Characteristics of Erythromycin Resistant Streptococcus pneumoniae with Preferred PCV Usage in Iran.
    PLoS One. 2016;11:e0167803.
    PubMed     Text format     Abstract available


  451. SAUNDERS-HASTINGS P, Reisman J, Krewski D
    Assessing the State of Knowledge Regarding the Effectiveness of Interventions to Contain Pandemic Influenza Transmission: A Systematic Review and Narrative Synthesis.
    PLoS One. 2016;11:e0168262.
    PubMed     Text format     Abstract available


  452. CHEN X, Li N, Bi S, Wang X, et al
    Co-Activation of Th17 and Antibody Responses Provides Efficient Protection against Mucosal Infection by Group A Streptococcus.
    PLoS One. 2016;11:e0168861.
    PubMed     Text format     Abstract available


  453. KOMATSU H, Inui A, Umetsu S, Tsunoda T, et al
    Evaluation of the G145R Mutant of the Hepatitis B Virus as a Minor Strain in Mother-to-Child Transmission.
    PLoS One. 2016;11:e0165674.
    PubMed     Text format     Abstract available


  454. TSEKOA TL, Lotter-Stark T, Buthelezi S, Chakauya E, et al
    Efficient In Vitro and In Vivo Activity of Glyco-Engineered Plant-Produced Rabies Monoclonal Antibodies E559 and 62-71-3.
    PLoS One. 2016;11:e0159313.
    PubMed     Text format     Abstract available


  455. JONGWE TI, Chapman R, Douglass N, Chetty S, et al
    HIV-1 Subtype C Mosaic Gag Expressed by BCG and MVA Elicits Persistent Effector T Cell Responses in a Prime-Boost Regimen in Mice.
    PLoS One. 2016;11:e0159141.
    PubMed     Text format     Abstract available


  456. KING EM, Oomeer S, Gilson R, Copas A, et al
    Oral Human Papillomavirus Infection in Men Who Have Sex with Men: A Systematic Review and Meta-Analysis.
    PLoS One. 2016;11:e0157976.
    PubMed     Text format     Abstract available


  457. SMITH GC, Delahay RJ, McDonald RA, Budgey R, et al
    Model of Selective and Non-Selective Management of Badgers (Meles meles) to Control Bovine Tuberculosis in Badgers and Cattle.
    PLoS One. 2016;11:e0167206.
    PubMed     Text format     Abstract available


    January 2015
  458. PREVATO M, Ferlenghi I, Bonci A, Uematsu Y, et al
    Expression and Characterization of Recombinant, Tetrameric and Enzymatically Active Influenza Neuraminidase for the Setup of an Enzyme-Linked Lectin-Based Assay.
    PLoS One. 2015;10:e0135474.
    PubMed     Text format     Abstract available


  459. DENG K, Liu R, Rao H, Jiang D, et al
    Antibodies Targeting Novel Neutralizing Epitopes of Hepatitis C Virus Glycoprotein Preclude Genotype 2 Virus Infection.
    PLoS One. 2015;10:e0138756.
    PubMed     Text format     Abstract available


  460. CHOI SJ, Kim MH, Jeon J, Kim OY, et al
    Active Immunization with Extracellular Vesicles Derived from Staphylococcus aureus Effectively Protects against Staphylococcal Lung Infections, Mainly via Th1 Cell-Mediated Immunity.
    PLoS One. 2015;10:e0136021.
    PubMed     Text format     Abstract available


  461. VAN DIJK CE, Hooiveld M, Jentink A, Isken LD, et al
    Experiences of General Practitioners and Practice Assistants during the Influenza A(H1N1) Pandemic in the Netherlands: A Cross-Sectional Survey.
    PLoS One. 2015;10:e0135666.
    PubMed     Text format     Abstract available


  462. POTEET E, Lewis P, Li F, Zhang S, et al
    A Novel Prime and Boost Regimen of HIV Virus-Like Particles with TLR4 Adjuvant MPLA Induces Th1 Oriented Immune Responses against HIV.
    PLoS One. 2015;10:e0136862.
    PubMed     Text format     Abstract available


  463. BILLINGS E, Sanders-Buell E, Bose M, Bradfield A, et al
    The Number and Complexity of Pure and Recombinant HIV-1 Strains Observed within Incident Infections during the HIV and Malaria Cohort Study Conducted in Kericho, Kenya, from 2003 to 2006.
    PLoS One. 2015;10:e0135124.
    PubMed     Text format     Abstract available


  464. JEYANATHAN M, Shao Z, Yu X, Harkness R, et al
    AdHu5Ag85A Respiratory Mucosal Boost Immunization Enhances Protection against Pulmonary Tuberculosis in BCG-Primed Non-Human Primates.
    PLoS One. 2015;10:e0135009.
    PubMed     Text format     Abstract available


  465. TEWAWONG N, Prachayangprecha S, Vichiwattana P, Korkong S, et al
    Assessing Antigenic Drift of Seasonal Influenza A(H3N2) and A(H1N1)pdm09 Viruses.
    PLoS One. 2015;10:e0139958.
    PubMed     Text format     Abstract available


  466. ADETIFA IM, Muhammad AK, Jeffries D, Donkor S, et al
    A Tuberculin Skin Test Survey and the Annual Risk of Mycobacterium tuberculosis Infection in Gambian School Children.
    PLoS One. 2015;10:e0139354.
    PubMed     Text format     Abstract available


  467. JONES-LOPEZ EC, White LF, Kirenga B, Mumbowa F, et al
    Cough Aerosol Cultures of Mycobacterium tuberculosis: Insights on TST / IGRA Discordance and Transmission Dynamics.
    PLoS One. 2015;10:e0138358.
    PubMed     Text format     Abstract available


  468. CHA SB, Kim WS, Kim JS, Kim H, et al
    Repeated Aerosolized-Boosting with Gamma-Irradiated Mycobacterium bovis BCG Confers Improved Pulmonary Protection against the Hypervirulent Mycobacterium tuberculosis Strain HN878 in Mice.
    PLoS One. 2015;10:e0141577.
    PubMed     Text format     Abstract available


  469. LEE YN, Kim MC, Lee YT, Hwang HS, et al
    Cross Protection against Influenza A Virus by Yeast-Expressed Heterologous Tandem Repeat M2 Extracellular Proteins.
    PLoS One. 2015;10:e0137822.
    PubMed     Text format     Abstract available


  470. OZEKI Y, Igarashi M, Doe M, Tamaru A, et al
    A New Screen for Tuberculosis Drug Candidates Utilizing a Luciferase-Expressing Recombinant Mycobacterium bovis Bacillus Calmette-Gueren.
    PLoS One. 2015;10:e0141658.
    PubMed     Text format     Abstract available


  471. WANG PC, Mwango A, Moberley S, Brockman BJ, et al
    A Cluster Randomised Trial on the Impact of Integrating Early Infant HIV Diagnosis with the Expanded Programme on Immunization on Immunization and HIV Testing Rates in Rural Health Facilities in Southern Zambia.
    PLoS One. 2015;10:e0141455.
    PubMed     Text format     Abstract available


  472. BADAMCHI-ZADEH A, McKay PF, Holland MJ, Paes W, et al
    Intramuscular Immunisation with Chlamydial Proteins Induces Chlamydia trachomatis Specific Ocular Antibodies.
    PLoS One. 2015;10:e0141209.
    PubMed     Text format     Abstract available


  473. WEBBY RJ, Weaver EA
    Centralized Consensus Hemagglutinin Genes Induce Protective Immunity against H1, H3 and H5 Influenza Viruses.
    PLoS One. 2015;10:e0140702.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: